The Role of Neuro-Immune Interactions in Chronic Pain: Implications for Clinical Practice

References

• Dahlhamer J, Lucas J, Zelaya C, et al. Prevalence of Chronic Pain and High-Impact Chronic Pain Among Adults — United States, 2016. MMWR Morb Mortal Wkly Rep. 2018;67(36):1001–1006. doi:10.15585/mmwr.mm6736a2
   PubMed Web of Science ®Google Scholar
• Zelaya CE, Dahlhamer JM, Lucas JW, Connor EM. Chronic Pain and High-impact Chronic Pain Among U.S. Adults, 2019. NCHS Data Brief. 2020;1(390):1–8.
   Google Scholar
• Cordell WH, Keene KK, Giles BK, Jones JB, Jones JH, Brizendine EJ. The high prevalence of pain in emergency medical care. Am J Emerg Med. 2002;20(3):165–169. doi:10.1053/ajem.2002.32643
   PubMed Web of Science ®Google Scholar
• Institute of Medicine (US) Committee on Advancing Pain Research, Care, and Education. Relieving Pain in America: a Blueprint for Transforming Prevention, Care, Education, and Research. National Academies Press (US); 2011. Available from: http://www.ncbi.nlm.nih.gov/books/NBK91497/. Accessed December 20, 2021.
   Google Scholar
• Stewart WF, Ricci JA, Chee E, Morganstein D, Lipton R. Lost Productive Time and Cost Due to Common Pain Conditions in the US Workforce. JAMA. 2003;290(18):2443–2454. doi:10.1001/jama.290.18.2443
   PubMed Web of Science ®Google Scholar
• Bonnie RJ, Schumacher MA, Clark JD, Kesselheim AS, Management P. Opioid Regulation: continuing Public Health Challenges. Am J Public Health. 2019;109(1):31–34. doi:10.2105/AJPH.2018.304881
   PubMed Web of Science ®Google Scholar
• Volkow ND, McLellan AT. Opioid Abuse in Chronic Pain — misconceptions and Mitigation Strategies. N Eng J Med. 2016;374(13):1253–1263. doi:10.1056/NEJMra1507771
   PubMed Web of Science ®Google Scholar
• Chiu IM, von Hehn CA, Woolf CJ. Neurogenic Inflammation – the Peripheral Nervous System’s Role in Host Defense and Immunopathology. Nat Neurosci. 2012;15(8):1063–1067. doi:10.1038/nn.3144
   PubMed Web of Science ®Google Scholar
• Ji RR, Chamessian A, Zhang YQ. Pain regulation by non-neuronal cells and inflammation. Science. 2016;354(6312):572–577. doi:10.1126/science.aaf8924
   PubMed Web of Science ®Google Scholar
• Ren K, Dubner R. Interactions between the immune and nervous systems in pain. Nat Med. 2010;16(11):1267–1276. doi:10.1038/nm.2234
   PubMed Web of Science ®Google Scholar
• Goadsby PJ, Edvinsson L, Ekman R. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol. 1990;28(2):183–187. doi:10.1002/ana.410280213
   PubMed Web of Science ®Google Scholar
• Mouraux A, Bannister K, Becker S, et al. Challenges and opportunities in translational pain research – an opinion paper of the working group on translational pain research of the European pain federation (EFIC). European J Pain. 2021;25(4):731–756. doi:10.1002/ejp.1730
   PubMed Web of Science ®Google Scholar
• Grace PM, Hutchinson MR, Maier SF, Watkins LR. Pathological pain and the neuroimmune interface. Nat Rev Immunol. 2014;14(4):217–231. doi:10.1038/nri3621
   PubMed Web of Science ®Google Scholar
• Baral P, Udit S, Chiu IM. Pain and immunity: implications for host defence. Nat Rev Immunol. 2019;19(7):433–447. doi:10.1038/s41577-019-0147-2
   PubMed Web of Science ®Google Scholar
• Hanisch UK. Microglia as a source and target of cytokines. Glia. 2002;40(2):140–155. doi:10.1002/glia.10161
   PubMed Web of Science ®Google Scholar
• Raghavendra V, Tanga F, DeLeo JA. Inhibition of microglial activation attenuates the development but not existing hypersensitivity in a rat model of neuropathy. J Pharmacol Exp Ther. 2003;306(2):624–630. doi:10.1124/jpet.103.052407
   PubMed Web of Science ®Google Scholar
• Park CK, Lü N, Xu ZZ, Liu T, Serhan CN, Ji RR. Resolving TRPV1- and TNF-α-mediated spinal cord synaptic plasticity and inflammatory pain with neuroprotectin D1. J Neurosci. 2011;31(42):15072–15085. doi:10.1523/JNEUROSCI.2443-11.2011
   PubMed Web of Science ®Google Scholar
• Gruber-Schoffnegger D, Drdla-Schutting R, Hönigsperger C, Wunderbaldinger G, Gassner M, Sandkühler J. Induction of thermal hyperalgesia and synaptic long-term potentiation in the spinal cord lamina I by TNF-α and IL-1β is mediated by glial cells. J Neurosci. 2013;33(15):6540–6551. doi:10.1523/JNEUROSCI.5087-12.2013
   PubMed Web of Science ®Google Scholar
• Kawasaki Y, Zhang L, Cheng JK, Ji RR. Cytokine mechanisms of central sensitization: distinct and overlapping role of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in regulating synaptic and neuronal activity in the superficial spinal cord. J Neurosci. 2008;28(20):5189–5194. doi:10.1523/JNEUROSCI.3338-07.2008
   PubMed Web of Science ®Google Scholar
• Chirila AM, Brown TE, Bishop RA, Bellono NW, Pucci FG, Kauer JA. Long-term potentiation of glycinergic synapses triggered by interleukin 1β. Proc Natl Acad Sci U S A. 2014;111(22):8263–8268. doi:10.1073/pnas.1401013111
   PubMed Web of Science ®Google Scholar
• Clark AK, Gruber-Schoffnegger D, Drdla-Schutting R, Gerhold KJ, Malcangio M, Sandkühler J. Selective activation of microglia facilitates synaptic strength. J Neurosci. 2015;35(11):4552–4570. doi:10.1523/JNEUROSCI.2061-14.2015
   PubMed Web of Science ®Google Scholar
• Gardoni F, Boraso M, Zianni E, et al. Distribution of interleukin-1 receptor complex at the synaptic membrane driven by interleukin-1β and NMDA stimulation. J Neuroinflammation. 2011;8(1):14. doi:10.1186/1742-2094-8-14
   PubMed Web of Science ®Google Scholar
• Baba H, Kohno T, Moore KA, Woolf CJ. Direct activation of rat spinal dorsal horn neurons by prostaglandin E2. J Neurosci. 2001;21(5):1750–1756.
   PubMed Web of Science ®Google Scholar
• Meves H. The Action of Prostaglandins on Ion Channels. Curr Neuropharmacol. 2006;4(1):41–57.
   PubMed Web of Science ®Google Scholar
• Nicol GD, Klingberg DK, Vasko MR. Prostaglandin E2 increases calcium conductance and stimulates release of substance P in avian sensory neurons. J Neurosci. 1992;12(5):1917–1927.
   PubMed Web of Science ®Google Scholar
• Samad TA, Moore KA, Sapirstein A, et al. Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature. 2001;410(6827):471–475. doi:10.1038/35068566
   PubMed Web of Science ®Google Scholar
• Nimmerjahn A, Kirchhoff F, Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science. 2005;308(5726):1314–1318. doi:10.1126/science.1110647
   PubMed Web of Science ®Google Scholar
• Ginhoux F, Greter M, Leboeuf M, et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science. 2010;330(6005):841–845. doi:10.1126/science.1194637
   PubMed Web of Science ®Google Scholar
• Ginhoux F, Lim S, Hoeffel G, Low D, Huber T. Origin and differentiation of microglia. Front Cell Neurosci. 2013;7:45. doi:10.3389/fncel.2013.00045
   PubMed Web of Science ®Google Scholar
• Rezaie P, Male D. Colonisation of the developing human brain and spinal cord by microglia: a review. Microsc Res Tech. 1999;45(6):359–382. doi:10.1002/(SICI)1097-0029(19990615)45:6<359::AID-JEMT4>3.0.CO;2-D
   PubMed Web of Science ®Google Scholar
• Svensson CI, Marsala M, Westerlund A, et al. Activation of p38 mitogen-activated protein kinase in spinal microglia is a critical link in inflammation-induced spinal pain processing. J Neurochem. 2003;86(6):1534–1544. doi:10.1046/j.1471-4159.2003.01969.x
   PubMed Web of Science ®Google Scholar
• Szepesi Z, Manouchehrian O, Bachiller S, Deierborg T. Bidirectional Microglia-Neuron Communication in Health and Disease. Front Cell Neurosci. 2018;12:323. doi:10.3389/fncel.2018.00323
   PubMed Web of Science ®Google Scholar
• Tsuda M, Shigemoto-Mogami Y, Koizumi S, et al. P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature. 2003;424(6950):778–783. doi:10.1038/nature01786
   PubMed Web of Science ®Google Scholar
• Zhou Z, Peng X, Hao S, Fink DJ, Mata M. HSV-mediated transfer of interleukin-10 reduces inflammatory pain through modulation of membrane tumor necrosis factor alpha in spinal cord microglia. Gene Ther. 2008;15(3):183–190. doi:10.1038/sj.gt.3303054
   PubMed Web of Science ®Google Scholar
• Kohno K, Shirasaka R, Yoshihara K, et al. A spinal microglia population involved in remitting and relapsing neuropathic pain. Science. 2022;376(6588):86–90. doi:10.1126/science.abf6805
   PubMed Web of Science ®Google Scholar
• Del Valle L, Schwartzman RJ, Alexander G. Spinal cord histopathological alterations in a patient with longstanding complex regional pain syndrome. Brain Behav Immun. 2009;23(1):85–91. doi:10.1016/j.bbi.2008.08.004
   PubMed Web of Science ®Google Scholar
• Janssen B, Vugts DJ, Windhorst AD, Mach RH. PET Imaging of Microglial Activation-Beyond Targeting TSPO. Molecules. 2018;23(3):E607. doi:10.3390/molecules23030607
   PubMed Web of Science ®Google Scholar
• Jeon SY, Seo S, Lee JS, et al. [11C]-(R)-PK11195 positron emission tomography in patients with complex regional pain syndrome. Medicine. 2017;96(1):e5735. doi:10.1097/MD.0000000000005735
   PubMed Web of Science ®Google Scholar
• Loggia ML, Chonde DB, Akeju O, et al. Evidence for brain glial activation in chronic pain patients. Brain. 2015;138(Pt 3):604–615. doi:10.1093/brain/awu377
   PubMed Web of Science ®Google Scholar
• Seo S, Jung YH, Lee D, et al. Abnormal neuroinflammation in fibromyalgia and CRPS using [11C]-(R)-PK11195 PET. PLoS One. 2021;16(2):e0246152. doi:10.1371/journal.pone.0246152
   PubMed Web of Science ®Google Scholar
• Albrecht DS, Ahmed SU, Kettner NW, et al. Neuroinflammation of the spinal cord and nerve roots in chronic radicular pain patients. Pain. 2018;159(5):968–977. doi:10.1097/j.pain.0000000000001171
   PubMed Web of Science ®Google Scholar
• Meyer JH, Braga J. Development and Clinical Application of Positron Emission Tomography Imaging Agents for Monoamine Oxidase B. Front Neurosci. 2021;15:773404. doi:10.3389/fnins.2021.773404
   PubMed Web of Science ®Google Scholar
• Albrecht DS, Forsberg A, Sandström A, et al. Brain glial activation in fibromyalgia - A multi-site positron emission tomography investigation. Brain Behav Immun. 2019;75:72–83. doi:10.1016/j.bbi.2018.09.018
   PubMed Web of Science ®Google Scholar
• Hutchinson MR, Ramos KM, Loram LC, et al. Evidence for a role of heat shock protein-90 in toll like receptor 4 mediated pain enhancement in rats. Neuroscience. 2009;164(4):1821–1832. doi:10.1016/j.neuroscience.2009.09.046
   PubMed Web of Science ®Google Scholar
• Masuda T, Ozono Y, Mikuriya S, et al. Dorsal horn neurons release extracellular ATP in a VNUT-dependent manner that underlies neuropathic pain. Nat Commun. 2016;7:12529. doi:10.1038/ncomms12529
   PubMed Web of Science ®Google Scholar
• Park JS, Svetkauskaite D, He Q, et al. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem. 2004;279(9):7370–7377. doi:10.1074/jbc.M306793200
   PubMed Web of Science ®Google Scholar
• Yang H, Hreggvidsdottir HS, Palmblad K, et al. A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release. Proc Natl Acad Sci U S A. 2010;107(26):11942–11947. doi:10.1073/pnas.1003893107
   PubMed Web of Science ®Google Scholar
• Yang H, Zeng Q, Silverman HA, et al. HMGB1 released from nociceptors mediates inflammation. PNAS. 2021;118:33. doi:10.1073/pnas.2102034118
   Web of Science ®Google Scholar
• Kim D, Kim MA, Cho IH, et al. A critical role of toll-like receptor 2 in nerve injury-induced spinal cord glial cell activation and pain hypersensitivity. J Biol Chem. 2007;282(20):14975–14983. doi:10.1074/jbc.M607277200
   PubMed Web of Science ®Google Scholar
• Tanga FY, Nutile-McMenemy N, DeLeo JA. The CNS role of Toll-like receptor 4 in innate neuroimmunity and painful neuropathy. Proc Natl Acad Sci U S A. 2005;102(16):5856–5861. doi:10.1073/pnas.0501634102
   PubMed Web of Science ®Google Scholar
• Huck NA, Siliezar-Doyle J, Haight ES, et al. Temporal Contribution of Myeloid-Lineage TLR4 to the Transition to Chronic Pain: a Focus on Sex Differences. J Neurosci. 2021;41(19):4349–4365. doi:10.1523/JNEUROSCI.1940-20.2021
   PubMed Web of Science ®Google Scholar
• Kobayashi K, Yamanaka H, Yanamoto F, Okubo M, Noguchi K. Multiple P2Y subtypes in spinal microglia are involved in neuropathic pain after peripheral nerve injury. Glia. 2012;60(10):1529–1539. doi:10.1002/glia.22373
   PubMed Web of Science ®Google Scholar
• Biber K, Tsuda M, Tozaki-Saitoh H, et al. Neuronal CCL21 up-regulates microglia P2X4 expression and initiates neuropathic pain development. EMBO J. 2011;30(9):1864–1873. doi:10.1038/emboj.2011.89
   PubMed Web of Science ®Google Scholar
• Tsuda M, Kuboyama K, Inoue T, Nagata K, Tozaki-Saitoh H, Inoue K. Behavioral phenotypes of mice lacking purinergic P2X4 receptors in acute and chronic pain assays. Mol Pain. 2009;5:28. doi:10.1186/1744-8069-5-28
   PubMed Web of Science ®Google Scholar
• Erblich B, Zhu L, Etgen AM, Dobrenis K, Pollard JW. Absence of colony stimulation factor-1 receptor results in loss of microglia, disrupted brain development and olfactory deficits. PLoS One. 2011;6(10):e26317. doi:10.1371/journal.pone.0026317
   PubMed Web of Science ®Google Scholar
• Guan Z, Kuhn JA, Wang X, et al. Injured sensory neuron–derived CSF1 induces microglial proliferation and DAP12-dependent pain. Nat Neurosci. 2016;19(1):94–101. doi:10.1038/nn.4189
   PubMed Web of Science ®Google Scholar
• Zhou LJ, Peng J, Xu YN, et al. Microglia Are Indispensable for Synaptic Plasticity in the Spinal Dorsal Horn and Chronic Pain. Cell Rep. 2019;27(13):3844–3859.e6. doi:10.1016/j.celrep.2019.05.087
   PubMed Web of Science ®Google Scholar
• Gu N, Peng J, Murugan M, et al. Spinal Microgliosis Due to Resident Microglial Proliferation Is Required for Pain Hypersensitivity after Peripheral Nerve Injury. Cell Rep. 2016;16(3):605–614. doi:10.1016/j.celrep.2016.06.018
   PubMed Web of Science ®Google Scholar
• Dai XM, Ryan GR, Hapel AJ, et al. Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects. Blood. 2002;99(1):111–120. doi:10.1182/blood.v99.1.111
   PubMed Web of Science ®Google Scholar
• Benner B, Good L, Quiroga D, et al. Pexidartinib, a Novel Small Molecule CSF-1R Inhibitor in Use for Tenosynovial Giant Cell Tumor: a Systematic Review of Pre-Clinical and Clinical Development. Drug Des Devel Ther. 2020;14:1693–1704. doi:10.2147/DDDT.S253232
   PubMed Web of Science ®Google Scholar
• Verge GM, Milligan ED, Maier SF, Watkins LR, Naeve GS, Foster AC. Fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) distribution in spinal cord and dorsal root ganglia under basal and neuropathic pain conditions. Eur J Neurosci. 2004;20(5):1150–1160. doi:10.1111/j.1460-9568.2004.03593.x
   PubMed Web of Science ®Google Scholar
• Clark AK, Yip PK, Grist J, et al. Inhibition of spinal microglial cathepsin S for the reversal of neuropathic pain. PNAS. 2007;104(25):10655–10660. doi:10.1073/pnas.0610811104
   PubMed Web of Science ®Google Scholar
• Milligan E, Zapata V, Schoeniger D, et al. An initial investigation of spinal mechanisms underlying pain enhancement induced by fractalkine, a neuronally released chemokine. Eur J Neurosci. 2005;22(11):2775–2782. doi:10.1111/j.1460-9568.2005.04470.x
   PubMed Web of Science ®Google Scholar
• Staniland AA, Clark AK, Wodarski R, et al. Reduced inflammatory and neuropathic pain and decreased spinal microglial response in fractalkine receptor (CX3CR1) knockout mice. J Neurochem. 2010;114(4):1143–1157. doi:10.1111/j.1471-4159.2010.06837.x
   PubMed Web of Science ®Google Scholar
• The future | kancera. Available from: https://kancera.com/en/research/the-future/. Accessed January 6, 2022.
   Google Scholar
• Ji RR, Xu ZZ, Wang X, Lo EH. Matrix metalloprotease regulation of neuropathic pain. Trends Pharmacol Sci. 2009;30(7):336–340. doi:10.1016/j.tips.2009.04.002
   PubMed Web of Science ®Google Scholar
• Kawasaki Y, Xu ZZ, Wang X, et al. Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain. Nat Med. 2008;14(3):331–336. doi:10.1038/nm1723
   PubMed Web of Science ®Google Scholar
• Berta T, Park CK, Xu ZZ, et al. Extracellular caspase-6 drives murine inflammatory pain via microglial TNF-α secretion. J Clin Invest. 2014;124(3):1173–1186. doi:10.1172/JCI72230
   PubMed Web of Science ®Google Scholar
• Berta T, Lee JE, Park CK. Unconventional Role of Caspase-6 in Spinal Microglia Activation and Chronic Pain. Mediators Inflamm. 2017;2017:9383184. doi:10.1155/2017/9383184
   PubMed Web of Science ®Google Scholar
• Calvo M, Zhu N, Tsantoulas C, et al. Neuregulin-ErbB signaling promotes microglial proliferation and chemotaxis contributing to microgliosis and pain after peripheral nerve injury. J Neurosci. 2010;30(15):5437–5450. doi:10.1523/JNEUROSCI.5169-09.2010
   PubMed Web of Science ®Google Scholar
• Viviani B, Bartesaghi S, Gardoni F, et al. Interleukin-1beta enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases. J Neurosci. 2003;23(25):8692–8700.
   PubMed Web of Science ®Google Scholar
• Chen G, Zhang YQ, Qadri YJ, Serhan CN, Ji RR. Microglia in Pain: detrimental and Protective Roles in Pathogenesis and Resolution of Pain. Neuron. 2018;100(6):1292–1311. doi:10.1016/j.neuron.2018.11.009
   PubMed Web of Science ®Google Scholar
• Yi MH, Liu YU, Umpierre AD, et al. Optogenetic activation of spinal microglia triggers chronic pain in mice. PLoS Biol. 2021;19(3):e3001154. doi:10.1371/journal.pbio.3001154
   PubMed Web of Science ®Google Scholar
• Coull JAM, Boudreau D, Bachand K, et al. Trans-synaptic shift in anion gradient in spinal lamina I neurons as a mechanism of neuropathic pain. Nature. 2003;424(6951):938–942. doi:10.1038/nature01868
   PubMed Web of Science ®Google Scholar
• Coull JAM, Beggs S, Boudreau D, et al. BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature. 2005;438(7070):1017–1021. doi:10.1038/nature04223
   PubMed Web of Science ®Google Scholar
• Keller AF, Beggs S, Salter MW, De Koninck Y. Transformation of the output of spinal lamina I neurons after nerve injury and microglia stimulation underlying neuropathic pain. Mol Pain. 2007;3:27. doi:10.1186/1744-8069-3-27
   PubMed Web of Science ®Google Scholar
• Dedek A, Xu J, Kandegedara CM, et al. Loss of STEP61 couples disinhibition to N-methyl-d-aspartate receptor potentiation in rodent and human spinal pain processing. Brain. 2019;142(6):1535–1546. doi:10.1093/brain/awz105
   PubMed Web of Science ®Google Scholar
• Malcangio M. Spinal mechanisms of neuropathic pain: is there a P2X4-BDNF controversy? Neurobiol Pain. 2017;1:1–5. doi:10.1016/j.ynpai.2017.04.001
   PubMedGoogle Scholar
• Trang T, Beggs S, Wan X, Salter MW. P2X4-receptor-mediated synthesis and release of brain-derived neurotrophic factor in microglia is dependent on calcium and p38-mitogen-activated protein kinase activation. J Neurosci. 2009;29(11):3518–3528. doi:10.1523/JNEUROSCI.5714-08.2009
   PubMed Web of Science ®Google Scholar
• Drilon A, Siena S, Ou SHI, et al. Safety and Antitumor Activity of the Multitargeted Pan-TRK, ROS1, and ALK Inhibitor Entrectinib: combined Results from Two Phase I Trials (ALKA-372-001 and STARTRK-1). Cancer Discov. 2017;7(4):400–409. doi:10.1158/2159-8290.CD-16-1237
   PubMed Web of Science ®Google Scholar
• Drilon A, Laetsch TW, Kummar S, et al. Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children. N Engl J Med. 2018;378(8):731–739. doi:10.1056/NEJMoa1714448
   PubMed Web of Science ®Google Scholar
• Hong S, Gronert K, Devchand PR, Moussignac RL, Serhan CN. Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation. J Biol Chem. 2003;278(17):14677–14687. doi:10.1074/jbc.M300218200
   PubMed Web of Science ®Google Scholar
• Serhan CN, de la Rosa X, Jouvene CC. Cutting Edge: human Vagus Produces Specialized Proresolving Mediators of Inflammation with Electrical Stimulation Reducing Proinflammatory Eicosanoids. J Immunol. 2018;201(11):3161–3165. doi:10.4049/jimmunol.1800806
   PubMed Web of Science ®Google Scholar
• Xu ZZ, Zhang L, Liu T, et al. Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions. Nat Med. 2010;16(5):592–597. doi:10.1038/nm.2123
   PubMed Web of Science ®Google Scholar
• Callan N, Hanes D, Bradley R. Early evidence of efficacy for orally administered SPM-enriched marine lipid fraction on quality of life and pain in a sample of adults with chronic pain. J Transl Med. 2020;18(1):401. doi:10.1186/s12967-020-02569-5
   PubMed Web of Science ®Google Scholar
• Geusens P, Wouters C, Nijs J, Jiang Y, Dequeker J. Long-term effect of omega-3 fatty acid supplementation in active rheumatoid arthritis. A 12-month, double-blind, controlled study. Arthritis Rheum. 1994;37(6):824–829. doi:10.1002/art.1780370608
   PubMed Web of Science ®Google Scholar
• Sofroniew MV, Vinters HV. Astrocytes: biology and pathology. Acta Neuropathol. 2010;119(1):7–35. doi:10.1007/s00401-009-0619-8
   PubMed Web of Science ®Google Scholar
• Araque A, Parpura V, Sanzgiri RP, Haydon PG. Tripartite synapses: glia, the unacknowledged partner. Trends Neurosci. 1999;22(5):208–215. doi:10.1016/s0166-2236(98)
   PubMed Web of Science ®Google Scholar
• Liddelow SA, Guttenplan KA, Clarke LE, et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017;541(7638):481–487. doi:10.1038/nature21029
   PubMed Web of Science ®Google Scholar
• Schafer DP, Lehrman EK, Stevens B. The “quad-partite” synapse: microglia-synapse interactions in the developing and mature CNS. Glia. 2013;61(1):24–36. doi:10.1002/glia.22389
   PubMed Web of Science ®Google Scholar
• Bennett MVL, Contreras JE, Bukauskas FF, Sáez JC. New roles for astrocytes: gap junction hemichannels have something to communicate. Trends Neurosci. 2003;26(11):610–617. doi:10.1016/j.tins.2003.09.008
   PubMed Web of Science ®Google Scholar
• Kohro Y, Matsuda T, Yoshihara K, et al. Spinal astrocytes in superficial laminae gate brainstem descending control of mechanosensory hypersensitivity. Nat Neurosci. 2020;23(11):1376–1387. doi:10.1038/s41593-020-00713-4
   PubMed Web of Science ®Google Scholar
• Colburn RW, Rickman AJ, DeLeo JA. The effect of site and type of nerve injury on spinal glial activation and neuropathic pain behavior. Exp Neurol. 1999;157(2):289–304. doi:10.1006/exnr.1999.7065
   PubMed Web of Science ®Google Scholar
• Gao YJ, Cheng JK, Zeng Q, et al. Selective inhibition of JNK with a peptide inhibitor attenuates pain hypersensitivity and tumor growth in a mouse skin cancer pain model. Exp Neurol. 2009;219(1):146–155. doi:10.1016/j.expneurol.2009.05.006
   PubMed Web of Science ®Google Scholar
• Garrison CJ, Dougherty PM, Kajander KC, Carlton SM. Staining of glial fibrillary acidic protein (GFAP) in lumbar spinal cord increases following a sciatic nerve constriction injury. Brain Res. 1991;565(1):1–7. doi:10.1016/0006-8993(91)
   PubMed Web of Science ®Google Scholar
• Mathewson AJ, Berry M. Observations on the astrocyte response to a cerebral stab wound in adult rats. Brain Res. 1985;327(1–2):61–69. doi:10.1016/0006-8993(85)
   PubMed Web of Science ®Google Scholar
• Raghavendra V, Tanga FY, DeLeo JA. Complete Freunds adjuvant-induced peripheral inflammation evokes glial activation and proinflammatory cytokine expression in the CNS. Eur J Neurosci. 2004;20(2):467–473. doi:10.1111/j.1460-9568.2004.03514.x
   PubMed Web of Science ®Google Scholar
• Zhang RX, Liu B, Wang L, et al. Spinal glial activation in a new rat model of bone cancer pain produced by prostate cancer cell inoculation of the tibia. Pain. 2005;118(1–2):125–136. doi:10.1016/j.pain.2005.08.001
   PubMed Web of Science ®Google Scholar
• Davies JE, Pröschel C, Zhang N, Noble M, Mayer-Pröschel M, Davies SJA. Transplanted astrocytes derived from BMP- or CNTF-treated glial-restricted precursors have opposite effects on recovery and allodynia after spinal cord injury. J Biol. 2008;7(7):24. doi:10.1186/jbiol85
   PubMedGoogle Scholar
• Gao Y-J, Zhang L, Ji -R-R. Spinal injection of TNF-α-activated astrocytes produces persistent pain symptom mechanical allodynia by releasing monocyte chemoattractant protein-1. Glia. 2010;58(15):1871–1880. doi:10.1002/glia.21056
   PubMed Web of Science ®Google Scholar
• Okada-Ogawa A, Suzuki I, Sessle BJ, et al. Astroglia in Medullary Dorsal Horn (Trigeminal Spinal Subnucleus Caudalis) Are Involved in Trigeminal Neuropathic Pain Mechanisms. J Neurosci. 2009;29(36):11161–11171. doi:10.1523/JNEUROSCI.3365-09.2009
   PubMed Web of Science ®Google Scholar
• Watkins RL, Martin D, Ulrich P, Tracey JK, Maier FS. Evidence for the involvement of spinal cord glia in subcutaneous formalin induced hyperalgesia in the rat. Pain. 1997;71(3):225–235. doi:10.1016/S0304-3959(97)03369-1
   PubMed Web of Science ®Google Scholar
• Nam Y, Kim J-H, Kim J-H, et al. Reversible Induction of Pain Hypersensitivity following Optogenetic Stimulation of Spinal Astrocytes. Cell Rep. 2016;17(11):3049–3061. doi:10.1016/j.celrep.2016.11.043
   PubMed Web of Science ®Google Scholar
• Shi Y, Gelman BB, Lisinicchia JG, Tang S-J. Chronic-pain-associated astrocytic reaction in the spinal cord dorsal horn of human immunodeficiency virus-infected patients. J Neurosci. 2012;32(32):10833–10840. doi:10.1523/JNEUROSCI.5628-11.2012
   PubMed Web of Science ®Google Scholar
• Liu Y, Jiang H, Qin X, Tian M, Zhang H. PET imaging of reactive astrocytes in neurological disorders. Eur J Nucl Med Mol Imaging. 2021. doi:10.1007/s00259-021-05640-5
   Web of Science ®Google Scholar
• Boche D, Gerhard A, Rodriguez-Vieitez E. Prospects and challenges of imaging neuroinflammation beyond TSPO in Alzheimer’s disease. Eur J Nucl Med Mol Imaging. 2019;46(13):2831–2847. doi:10.1007/s00259-019-04462-w
   PubMed Web of Science ®Google Scholar
• Guilarte TR. TSPO in diverse CNS pathologies and psychiatric disease: a critical review and a way forward. Pharmacol Ther. 2019;194:44–58. doi:10.1016/j.pharmthera.2018.09.003
   PubMed Web of Science ®Google Scholar
• Tournier BB, Tsartsalis S, Ceyzériat K, et al. Astrocytic TSPO Upregulation Appears Before Microglial TSPO in Alzheimer’s Disease. J Alzheimers Dis. 2020;77(3):1043–1056. doi:10.3233/JAD-200136
   PubMed Web of Science ®Google Scholar
• Lu Y, Jiang B-C, Cao D-L, et al. TRAF6 upregulation in spinal astrocytes maintains neuropathic pain by integrating TNF-α and IL-1β signaling. Pain. 2014;155(12):2618–2629. doi:10.1016/j.pain.2014.09.027
   PubMed Web of Science ®Google Scholar
• Grosche J, Matyash V, Möller T, Verkhratsky A, Reichenbach A, Kettenmann H. Microdomains for neuron–glia interaction: parallel fiber signaling to Bergmann glial cells. Nat Neurosci. 1999;2(2):139–143. doi:10.1038/5692
   PubMed Web of Science ®Google Scholar
• Guo W, Wang H, Watanabe M, et al. Glial-cytokine-neuronal interactions underlying the mechanisms of persistent pain. J Neurosci. 2007;27(22):6006–6018. doi:10.1523/JNEUROSCI.0176-07.2007
   PubMed Web of Science ®Google Scholar
• Xie W, Strong JA, Meij JTA, Zhang JM, Yu L. Neuropathic pain: early spontaneous afferent activity is the trigger. Pain. 2005;116(3):243–256. doi:10.1016/j.pain.2005.04.017
   PubMed Web of Science ®Google Scholar
• Ikeda H, Tsuda M, Inoue K, Murase K. Long-term potentiation of neuronal excitation by neuron-glia interactions in the rat spinal dorsal horn. Eur J Neurosci. 2007;25(5):1297–1306. doi:10.1111/j.1460-9568.2007.05386.x
   PubMed Web of Science ®Google Scholar
• Ziak D, Chvátal A, Syková E. Glutamate-, kainate- and NMDA-evoked membrane currents in identified glial cells in rat spinal cord slice. Physiol Res. 1998;47(5):365–375.
   PubMed Web of Science ®Google Scholar
• Fields RD, Burnstock G. Purinergic signalling in neuron-glia interactions. Nat Rev Neurosci. 2006;7(6):423–436. doi:10.1038/nrn1928
   PubMed Web of Science ®Google Scholar
• Nakagawa T, Wakamatsu K, Zhang N, et al. Intrathecal administration of ATP produces long-lasting allodynia in rats: differential mechanisms in the phase of the induction and maintenance. Neuroscience. 2007;147(2):445–455. doi:10.1016/j.neuroscience.2007.03.045
   PubMed Web of Science ®Google Scholar
• Li Y, Zhang H, Zhang H, Kosturakis AK, Jawad AB, Dougherty PM. Toll-like receptor 4 signaling contributes to Paclitaxel-induced peripheral neuropathy. J Pain. 2014;15(7):712–725. doi:10.1016/j.jpain.2014.04.001
   PubMed Web of Science ®Google Scholar
• Jiang BC, Cao DL, Zhang X, et al. CXCL13 drives spinal astrocyte activation and neuropathic pain via CXCR5. J Clin Invest. 2016;126(2):745–761. doi:10.1172/JCI81950
   PubMed Web of Science ®Google Scholar
• Klimatcheva E, Pandina T, Reilly C, et al. CXCL13 antibody for the treatment of autoimmune disorders. BMC Immunol. 2015;16(1):6. doi:10.1186/s12865-015-0068-1
   PubMedGoogle Scholar
• Eclancher F, Perraud F, Faltin J, Labourdette G, Sensenbrenner M. Reactive astrogliosis after basic fibroblast growth factor (bFGF) injection in injured neonatal rat brain. Glia. 1990;3(6):502–509. doi:10.1002/glia.440030609
   PubMed Web of Science ®Google Scholar
• Ferrara N, Ousley F, Gospodarowicz D. Bovine brain astrocytes express basic fibroblast growth factor, a neurotropic and angiogenic mitogen. Brain Res. 1988;462(2):223–232. doi:10.1016/0006-8993(88)
   PubMed Web of Science ®Google Scholar
• Ji RR, Zhang Q, Zhang X, et al. Prominent expression of bFGF in dorsal root ganglia after axotomy. Eur J Neurosci. 1995;7(12):2458–2468. doi:10.1111/j.1460-9568.1995.tb01044.x
   PubMed Web of Science ®Google Scholar
• Madiai F, Hussain SRA, Goettl VM, Burry RW, Stephens RL, Hackshaw KV. Upregulation of FGF-2 in reactive spinal cord astrocytes following unilateral lumbar spinal nerve ligation. Exp Brain Res. 2003;148(3):366–376. doi:10.1007/s00221-002-1286-3
   PubMed Web of Science ®Google Scholar
• Madiai F, Goettl VM, Hussain SR, Clairmont AR, Stephens RL, Hackshaw KV. Anti-fibroblast growth factor-2 antibodies attenuate mechanical allodynia in a rat model of neuropathic pain. J Mol Neurosci. 2005;27(3):315–324. doi:10.1385/JMN:27:3:
   PubMed Web of Science ®Google Scholar
• Hui Q, Jin Z, Li X, Liu C, Wang X, Family: FGF. From Drug Development to Clinical Application. Int J Mol Sci. 2018;19(7):1875. doi:10.3390/ijms19071875
   PubMed Web of Science ®Google Scholar
• Ji RR, Donnelly CR, Nedergaard M. Astrocytes in chronic pain and itch. Nat Rev Neurosci. 2019;20(11):667–685. doi:10.1038/s41583-019-0218-1
   PubMed Web of Science ®Google Scholar
• Guptarak J, Wanchoo S, Durham-Lee J, et al. Inhibition of IL-6 signaling: a novel therapeutic approach to treating spinal cord injury pain. Pain. 2013;154(7):1115–1128. doi:10.1016/j.pain.2013.03.026
   PubMed Web of Science ®Google Scholar
• Wei F, Guo W, Zou S, Ren K, Dubner R. Supraspinal Glial–Neuronal Interactions Contribute to Descending Pain Facilitation. J Neurosci. 2008;28(42):10482–10495. doi:10.1523/JNEUROSCI.3593-08.2008
   PubMed Web of Science ®Google Scholar
• Zhang RX, Li A, Liu B, et al. IL-1ra alleviates inflammatory hyperalgesia through preventing phosphorylation of NMDA receptor NR-1 subunit in rats. Pain. 2008;135(3):232–239. doi:10.1016/j.pain.2007.05.023
   PubMed Web of Science ®Google Scholar
• Kolhekar R, Meller ST, Gebhart GF. N-methyl-D-aspartate receptor-mediated changes in thermal nociception: allosteric modulation at glycine and polyamine recognition sites. Neuroscience. 1994;63(4):925–936. doi:10.1016/0306-4522(94)
   PubMed Web of Science ®Google Scholar
• Wolosker H. D-serine regulation of NMDA receptor activity. Sci STKE. 2006;2006(356):pe41. doi:10.1126/stke.3562006pe41
   PubMedGoogle Scholar
• Chen G, Park CK, Xie RG, Berta T, Nedergaard M, Ji RR. Connexin-43 induces chemokine release from spinal cord astrocytes to maintain late-phase neuropathic pain in mice. Brain. 2014;137(8):2193–2209. doi:10.1093/brain/awu140
   PubMed Web of Science ®Google Scholar
• Kang J, Kang N, Lovatt D, et al. Connexin 43 hemichannels are permeable to ATP. J Neurosci. 2008;28(18):4702–4711. doi:10.1523/JNEUROSCI.5048-07.2008
   PubMed Web of Science ®Google Scholar
• Gao YJ, Zhang L, Samad OA, et al. JNK-induced MCP-1 production in spinal cord astrocytes contributes to central sensitization and neuropathic pain. J Neurosci. 2009;29(13):4096–4108. doi:10.1523/JNEUROSCI.3623-08.2009
   PubMed Web of Science ®Google Scholar
• Lazaar AL, Miller BE, Donald AC, et al. CXCR2 antagonist for patients with chronic obstructive pulmonary disease with chronic mucus hypersecretion: a Phase 2b trial. Respir Res. 2020;21(1):149. doi:10.1186/s12931-020-01401-4
   PubMed Web of Science ®Google Scholar
• Jeanson T, Duchêne A, Richard D, et al. Potentiation of Amitriptyline Anti-Hyperalgesic-Like Action By Astroglial Connexin 43 Inhibition in Neuropathic Rats. Sci Rep. 2016;6:38766. doi:10.1038/srep38766
   PubMed Web of Science ®Google Scholar
• Laird DW, Lampe PD. Therapeutic strategies targeting connexins. Nat Rev Drug Discov. 2018;17(12):905–921. doi:10.1038/nrd.2018.138
   PubMed Web of Science ®Google Scholar
• Silberstein SD. Tonabersat, a novel gap-junction modulator for the prevention of migraine. Cephalalgia. 2009;29(Suppl 2):28–35. doi:10.1111/j.1468-2982.2009.01973.x
   PubMed Web of Science ®Google Scholar
• Gosselin RD, Varela C, Banisadr G, et al. Constitutive expression of CCR2 chemokine receptor and inhibition by MCP-1/CCL2 of GABA-induced currents in spinal cord neurones. J Neurochem. 2005;95(4):1023–1034. doi:10.1111/j.1471-4159.2005.03431.x
   PubMed Web of Science ®Google Scholar
• White FA, Sun J, Waters SM, et al. Excitatory monocyte chemoattractant protein-1 signaling is up-regulated in sensory neurons after chronic compression of the dorsal root ganglion. Proc Natl Acad Sci U S A. 2005;102(39):14092–14097. doi:10.1073/pnas.0503496102
   PubMed Web of Science ®Google Scholar
• Ma SB, Xian H, Wu WB, et al. CCL2 facilitates spinal synaptic transmission and pain via interaction with presynaptic CCR2 in spinal nociceptor terminals. Mol Brain. 2020;13(1):161. doi:10.1186/s13041-020-00701-6
   PubMed Web of Science ®Google Scholar
• Abbadie C, Lindia JA, Cumiskey AM, et al. Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2. Proc Natl Acad Sci U S A. 2003;100(13):7947–7952. doi:10.1073/pnas.1331358100
   PubMed Web of Science ®Google Scholar
• Bhangoo S, Ren D, Miller RJ, et al. Delayed functional expression of neuronal chemokine receptors following focal nerve demyelination in the rat: a mechanism for the development of chronic sensitization of peripheral nociceptors. Mol Pain. 2007;3:38. doi:10.1186/1744-8069-3-38
   PubMed Web of Science ®Google Scholar
• Bhangoo SK, Ripsch MS, Buchanan DJ, Miller RJ, White FA. Increased chemokine signaling in a model of HIV1-associated peripheral neuropathy. Mol Pain. 2009;5:48. doi:10.1186/1744-8069-5-48
   PubMed Web of Science ®Google Scholar
• Zhang J, Shi XQ, Echeverry S, Mogil JS, De Koninck Y, Rivest S. Expression of CCR2 in both resident and bone marrow-derived microglia plays a critical role in neuropathic pain. J Neurosci. 2007;27(45):12396–12406. doi:10.1523/JNEUROSCI.3016-07.2007
   PubMed Web of Science ®Google Scholar
• Huang YH, Bergles DE. Glutamate transporters bring competition to the synapse. Curr Opin Neurobiol. 2004;14(3):346–352. doi:10.1016/j.conb.2004.05.007
   PubMed Web of Science ®Google Scholar
• Sung B, Lim G, Mao J. Altered expression and uptake activity of spinal glutamate transporters after nerve injury contribute to the pathogenesis of neuropathic pain in rats. J Neurosci. 2003;23(7):2899–2910.
   PubMed Web of Science ®Google Scholar
• Wang W, Wang W, Wang Y, Huang J, Wu S, Li YQ. Temporal changes of astrocyte activation and glutamate transporter-1 expression in the spinal cord after spinal nerve ligation-induced neuropathic pain. Anat Rec. 2008;291(5):513–518. doi:10.1002/ar.20673
   Google Scholar
• Xin WJ, Weng HR, Dougherty PM. Plasticity in expression of the glutamate transporters GLT-1 and GLAST in spinal dorsal horn glial cells following partial sciatic nerve ligation. Mol Pain. 2009;5:15. doi:10.1186/1744-8069-5-15
   PubMed Web of Science ®Google Scholar
• Maeda S, Kawamoto A, Yatani Y, Shirakawa H, Nakagawa T, Kaneko S. Gene transfer of GLT-1, a glial glutamate transporter, into the spinal cord by recombinant adenovirus attenuates inflammatory and neuropathic pain in rats. Mol Pain. 2008;4:65. doi:10.1186/1744-8069-4-65
   PubMed Web of Science ®Google Scholar
• Weng HR, Chen JH, Cata JP. Inhibition of glutamate uptake in the spinal cord induces hyperalgesia and increased responses of spinal dorsal horn neurons to peripheral afferent stimulation. Neuroscience. 2006;138(4):1351–1360. doi:10.1016/j.neuroscience.2005.11.061
   PubMed Web of Science ®Google Scholar
• Carbone M, Duty S, Rattray M. Riluzole elevates GLT-1 activity and levels in striatal astrocytes. Neurochem Int. 2012;60(1):31–38. doi:10.1016/j.neuint.2011.10.017
   PubMed Web of Science ®Google Scholar
• Galer BS, Twilling LL, Harle J, Cluff RS, Friedman E, Rowbotham MC. Lack of efficacy of riluzole in the treatment of peripheral neuropathic pain conditions. Neurology. 2000;55(7):971–975. doi:10.1212/wnl.55.7.971
   PubMed Web of Science ®Google Scholar
• Cao L, DeLeo JA. CNS-infiltrating CD4+ T lymphocytes contribute to murine spinal nerve transection-induced neuropathic pain. Eur J Immunol. 2008;38(2):448–458. doi:10.1002/eji.200737485
   PubMed Web of Science ®Google Scholar
• Du B, Ding YQ, Xiao X, Ren HY, Su BY, Qi JG. CD4+ αβ T cell infiltration into the leptomeninges of lumbar dorsal roots contributes to the transition from acute to chronic mechanical allodynia after adult rat tibial nerve injuries. J Neuroinflammation. 2018;15(1):81. doi:10.1186/s12974-018-1115-7
   PubMed Web of Science ®Google Scholar
• Kobayashi Y, Kiguchi N, Fukazawa Y, Saika F, Maeda T, Kishioka S. Macrophage-T cell interactions mediate neuropathic pain through the glucocorticoid-induced tumor necrosis factor ligand system. J Biol Chem. 2015;290(20):12603–12613. doi:10.1074/jbc.M115.636506
   PubMed Web of Science ®Google Scholar
• Moalem G, Xu K, Yu L. T lymphocytes play a role in neuropathic pain following peripheral nerve injury in rats. Neuroscience. 2004;129(3):767–777. doi:10.1016/j.neuroscience.2004.08.035
   PubMed Web of Science ®Google Scholar
• Sorge RE, Mapplebeck JCS, Rosen S, et al. Different immune cells mediate mechanical pain hypersensitivity in male and female mice. Nat Neurosci. 2015;18(8):1081–1083. doi:10.1038/nn.4053
   PubMed Web of Science ®Google Scholar
• Basso L, Boué J, Mahiddine K, et al. Endogenous analgesia mediated by CD4(+) T lymphocytes is dependent on enkephalins in mice. J Neuroinflammation. 2016;13(1):132. doi:10.1186/s12974-016-0591-x
   PubMed Web of Science ®Google Scholar
• Krukowski K, Eijkelkamp N, Laumet G, et al. CD8+ T Cells and Endogenous IL-10 Are Required for Resolution of Chemotherapy-Induced Neuropathic Pain. J Neurosci. 2016;36(43):11074–11083. doi:10.1523/JNEUROSCI.3708-15.2016
   PubMed Web of Science ®Google Scholar
• Laumet G, Edralin JD, Dantzer R, Heijnen CJ, Kavelaars A. Cisplatin educates CD8+ T cells to prevent and resolve chemotherapy-induced peripheral neuropathy in mice. Pain. 2019;160(6):1459–1468. doi:10.1097/j.pain.0000000000001512
   PubMed Web of Science ®Google Scholar
• Liu XJ, Zhang Y, Liu T, et al. Nociceptive neurons regulate innate and adaptive immunity and neuropathic pain through MyD88 adapter. Cell Res. 2014;24(11):1374–1377. doi:10.1038/cr.2014.106
   PubMed Web of Science ®Google Scholar
• Petrović J, Silva JR, Bannerman CA, et al. γδ T Cells Modulate Myeloid Cell Recruitment but Not Pain During Peripheral Inflammation. Front Immunol. 2019;10:473. doi:10.3389/fimmu.2019.00473
   PubMed Web of Science ®Google Scholar
• Luchting B, Rachinger-Adam B, Zeitler J, et al. Disrupted TH17/Treg balance in patients with chronic low back pain. PLoS One. 2014;9(8):e104883. doi:10.1371/journal.pone.0104883
   PubMed Web of Science ®Google Scholar
• Luchting B, Rachinger-Adam B, Heyn J, Hinske LC, Kreth S, Azad SC. Anti-inflammatory T-cell shift in neuropathic pain. J Neuroinflammation. 2015;12:12. doi:10.1186/s12974-014-0225-0
   PubMed Web of Science ®Google Scholar
• Mangiacavalli S, Corso A, De Amici M, et al. Emergent T-helper 2 profile with high interleukin-6 levels correlates with the appearance of bortezomib-induced neuropathic pain. Br J Haematol. 2010;149(6):916–918. doi:10.1111/j.1365-2141.2010.08138.x
   PubMed Web of Science ®Google Scholar
• Gattlen C, Clarke CB, Piller N, et al. Spinal Cord T-Cell Infiltration in the Rat Spared Nerve Injury Model: a Time Course Study. Int J Mol Sci. 2016;17(3):352. doi:10.3390/ijms17030352
   PubMed Web of Science ®Google Scholar
• Kipnis J, Gadani S, Derecki NC. Pro-cognitive properties of T cells. Nat Rev Immunol. 2012;12(9):663–669. doi:10.1038/nri3280
   PubMed Web of Science ®Google Scholar
• Hu P, McLachlan EM. Macrophage and lymphocyte invasion of dorsal root ganglia after peripheral nerve lesions in the rat. Neuroscience. 2002;112(1):23–38. doi:10.1016/s0306-4522(02)
   PubMed Web of Science ®Google Scholar
• Kivisäkk P, Imitola J, Rasmussen S, et al. Localizing central nervous system immune surveillance: meningeal antigen-presenting cells activate T cells during experimental autoimmune encephalomyelitis. Ann Neurol. 2009;65(4):457–469. doi:10.1002/ana.21379
   PubMed Web of Science ®Google Scholar
• Costigan M, Moss A, Latremoliere A, et al. T-cell infiltration and signaling in the adult dorsal spinal cord is a major contributor to neuropathic pain-like hypersensitivity. J Neurosci. 2009;29(46):14415–14422. doi:10.1523/JNEUROSCI.4569-09.2009
   PubMed Web of Science ®Google Scholar
• Leger T, Grist J, D’Acquisto F, Clark AK, Malcangio M. Glatiramer acetate attenuates neuropathic allodynia through modulation of adaptive immune cells. J Neuroimmunol. 2011;234(1–2):19–26. doi:10.1016/j.jneuroim.2011.01.005
   PubMed Web of Science ®Google Scholar
• Kuhn JA, Vainchtein ID, Braz J, et al. Regulatory T-cells inhibit microglia-induced pain hypersensitivity in female mice. Elife. 2021;10:e69056. doi:10.7554/eLife.69056
   PubMed Web of Science ®Google Scholar
• Luo X, Chen O, Wang Z, et al. IL-23/IL-17A/TRPV1 axis produces mechanical pain via macrophage-sensory neuron crosstalk in female mice. Neuron. 2021;109(17):2691–2706.e5. doi:10.1016/j.neuron.2021.06.015
   PubMed Web of Science ®Google Scholar
• Ganor Y, Besser M, Ben-Zakay N, Unger T, Levite M. Human T cells express a functional ionotropic glutamate receptor GluR3, and glutamate by itself triggers integrin-mediated adhesion to laminin and fibronectin and chemotactic migration. J Immunol. 2003;170(8):4362–4372. doi:10.4049/jimmunol.170.8.4362
   PubMed Web of Science ®Google Scholar
• Mikami N, Matsushita H, Kato T, et al. Calcitonin gene-related peptide is an important regulator of cutaneous immunity: effect on dendritic cell and T cell functions. J Immunol. 2011;186(12):6886–6893. doi:10.4049/jimmunol.1100028
   PubMed Web of Science ®Google Scholar
• Rameshwar P, Gascon P, Ganea D. Immunoregulatory effects of neuropeptides. Stimulation of interleukin-2 production by substance p. J Neuroimmunol. 1992;37(1–2):65–74. doi:10.1016/0165-5728(92)90156-f
   PubMed Web of Science ®Google Scholar
• Kleinschnitz C, Hofstetter HH, Meuth SG, Braeuninger S, Sommer C, Stoll G. T cell infiltration after chronic constriction injury of mouse sciatic nerve is associated with interleukin-17 expression. Exp Neurol. 2006;200(2):480–485. doi:10.1016/j.expneurol.2006.03.014
   PubMed Web of Science ®Google Scholar
• Laumet G, Ma J, Robison AJ, Kumari S, Heijnen CJ, Kavelaars AT. Cells as an Emerging Target for Chronic Pain Therapy. Front Mol Neurosci. 2019;12:216. doi:10.3389/fnmol.2019.00216
   PubMed Web of Science ®Google Scholar
• Vicuña L, Strochlic DE, Latremoliere A, et al. The serine protease inhibitor SerpinA3N attenuates neuropathic pain by inhibiting T cell-derived leukocyte elastase. Nat Med. 2015;21(5):518–523. doi:10.1038/nm.3852
   PubMed Web of Science ®Google Scholar
• Mizuno T, Zhang G, Takeuchi H, et al. Interferon-gamma directly induces neurotoxicity through a neuron specific, calcium-permeable complex of IFN-gamma receptor and AMPA GluR1 receptor. FASEB J. 2008;22(6):1797–1806. doi:10.1096/fj.07-099499
   PubMed Web of Science ®Google Scholar
• Tan PH, Ji J, Yeh CC, Ji RR. Interferons in Pain and Infections: emerging Roles in Neuro-Immune and Neuro-Glial Interactions. Front Immunol. 2021;12:783725. doi:10.3389/fimmu.2021.783725
   PubMed Web of Science ®Google Scholar
• Donnelly CR, Jiang C, Andriessen AS, et al. STING controls nociception via type I interferon signalling in sensory neurons. Nature. 2021;591(7849):275–280. doi:10.1038/s41586-020-03151-1
   PubMed Web of Science ®Google Scholar
• Fargali S, Sadahiro M, Jiang C, et al. Role of neurotrophins in the development and function of neural circuits that regulate energy homeostasis. J Mol Neurosci. 2012;48(3):654–659. doi:10.1007/s12031-012-9790-9
   PubMed Web of Science ®Google Scholar
• Labuz D, Schreiter A, Schmidt Y, Brack A, Machelska H. T lymphocytes containing β-endorphin ameliorate mechanical hypersensitivity following nerve injury. Brain Behav Immun. 2010;24(7):1045–1053. doi:10.1016/j.bbi.2010.04.001
   PubMed Web of Science ®Google Scholar
• Basso L, Garnier L, Bessac A, et al. T-lymphocyte-derived enkephalins reduce Th1/Th17 colitis and associated pain in mice. J Gastroenterol. 2018;53(2):215–226. doi:10.1007/s00535-017-1341-2
   PubMed Web of Science ®Google Scholar
• Boué J, Basso L, Cenac N, et al. Endogenous regulation of visceral pain via production of opioids by colitogenic CD4(+) T cells in mice. Gastroenterology. 2014;146(1):166–175. doi:10.1053/j.gastro.2013.09.020
   PubMed Web of Science ®Google Scholar
• Jessen KR, Mirsky R. The origin and development of glial cells in peripheral nerves. Nat Rev Neurosci. 2005;6(9):671–682. doi:10.1038/nrn1746
   PubMed Web of Science ®Google Scholar
• Haberberger RV, Barry C, Dominguez N, Matusica D. Human Dorsal Root Ganglia. Front Cell Neurosci. 2019;13:271. doi:10.3389/fncel.2019.00271
   PubMed Web of Science ®Google Scholar
• Hanani M, Spray DC. Emerging importance of satellite glia in nervous system function and dysfunction. Nat Rev Neurosci. 2020;21(9):485–498. doi:10.1038/s41583-020-0333-z
   PubMed Web of Science ®Google Scholar
• Pannese E, Ledda M, Cherkas PS, Huang TY, Hanani M. Satellite cell reactions to axon injury of sensory ganglion neurons: increase in number of gap junctions and formation of bridges connecting previously separate perineuronal sheaths. Anat Embryol (Berl). 2003;206(5):337–347. doi:10.1007/s00429-002-0301-6
   PubMedGoogle Scholar
• Dublin P, Hanani M. Satellite glial cells in sensory ganglia: their possible contribution to inflammatory pain. Brain Behav Immun. 2007;21(5):592–598. doi:10.1016/j.bbi.2006.11.011
   PubMed Web of Science ®Google Scholar
• Hanani M, Blum E, Liu S, Peng L, Liang S. Satellite glial cells in dorsal root ganglia are activated in streptozotocin-treated rodents. J Cell Mol Med. 2014;18(12):2367–2371. doi:10.1111/jcmm.12406
   PubMed Web of Science ®Google Scholar
• Song J, Ying Y, Wang W, et al. The role of P2X7R/ERK signaling in dorsal root ganglia satellite glial cells in the development of chronic postsurgical pain induced by skin/muscle incision and retraction (SMIR). Brain Behav Immun. 2018;69:180–189. doi:10.1016/j.bbi.2017.11.011
   PubMed Web of Science ®Google Scholar
• Takeda M, Tanimoto T, Kadoi J, et al. Enhanced excitability of nociceptive trigeminal ganglion neurons by satellite glial cytokine following peripheral inflammation. Pain. 2007;129(1–2):155–166. doi:10.1016/j.pain.2006.10.007
   PubMed Web of Science ®Google Scholar
• Takeda M, Takahashi M, Matsumoto S. Contribution of the activation of satellite glia in sensory ganglia to pathological pain. Neurosci Biobehav Rev. 2009;33(6):784–792. doi:10.1016/j.neubiorev.2008.12.005
   PubMed Web of Science ®Google Scholar
• Huang LY, Neher E. Ca(2+)-dependent exocytosis in the somata of dorsal root ganglion neurons. Neuron. 1996;17(1):135–145. doi:10.1016/s0896-6273(00)80287-1
   PubMed Web of Science ®Google Scholar
• Li J, Vause CV, Durham PL. Calcitonin gene-related peptide stimulation of nitric oxide synthesis and release from trigeminal ganglion glial cells. Brain Res. 2008;1196:22–32. doi:10.1016/j.brainres.2007.12.028
   PubMed Web of Science ®Google Scholar
• Matsuka Y, Neubert JK, Maidment NT, Spigelman I. Concurrent release of ATP and substance P within Guinea pig trigeminal ganglia in vivo. Brain Res. 2001;915(2):248–255. doi:10.1016/s0006-8993(01)
   PubMed Web of Science ®Google Scholar
• Tanaka T, Minami M, Nakagawa T, Satoh M. Enhanced production of monocyte chemoattractant protein-1 in the dorsal root ganglia in a rat model of neuropathic pain: possible involvement in the development of neuropathic pain. Neurosci Res. 2004;48(4):463–469. doi:10.1016/j.neures.2004.01.004
   PubMed Web of Science ®Google Scholar
• Zhang X, Chen Y, Wang C, Huang LYM. Neuronal somatic ATP release triggers neuron-satellite glial cell communication in dorsal root ganglia. Proc Natl Acad Sci U S A. 2007;104(23):9864–9869. doi:10.1073/pnas.0611048104
   PubMed Web of Science ®Google Scholar
• Berger UV, Hediger MA. Distribution of the glutamate transporters GLAST and GLT-1 in rat circumventricular organs, meninges, and dorsal root ganglia. J Comparative Neurol. 2000;421(3):385–399. doi:10.1002/(SICI)1096-9861(20000605)421:3<385::
   PubMed Web of Science ®Google Scholar
• Castillo C, Norcini M, Martin Hernandez LA, Correa G, Blanck TJJ, Recio-Pinto E. Satellite glia cells in dorsal root ganglia express functional NMDA receptors. Neuroscience. 2013;240:135–146. doi:10.1016/j.neuroscience.2013.02.031
   PubMed Web of Science ®Google Scholar
• Marriott I. The role of tachykinins in central nervous system inflammatory responses. Front Biosci. 2004;9:2153–2165. doi:10.2741/1377
   PubMed Web of Science ®Google Scholar
• Neubert JK, Maidment NT, Matsuka Y, Adelson DW, Kruger L, Spigelman I. Inflammation-induced changes in primary afferent-evoked release of substance P within trigeminal ganglia in vivo. Brain Res. 2000;871(2):181–191. doi:10.1016/s0006-8993(00)
   PubMed Web of Science ®Google Scholar
• Urits I, Jones MR, Gress K, et al. CGRP Antagonists for the Treatment of Chronic Migraines: a Comprehensive Review. Curr Pain Headache Rep. 2019;23(5):29. doi:10.1007/s11916-019-0768-y
   PubMed Web of Science ®Google Scholar
• Filippov AK, Fernández-Fernández JM, Marsh SJ, Simon J, Barnard EA, Brown DA. Activation and inhibition of neuronal G protein-gated inwardly rectifying K(+) channels by P2Y nucleotide receptors. Mol Pharmacol. 2004;66(3):468–477. doi:10.1124/mol.66.3
   PubMed Web of Science ®Google Scholar
• Chen Y, Zhang X, Wang C, Li G, Gu Y, Huang LYM. Activation of P2X7 receptors in glial satellite cells reduces pain through downregulation of P2X3 receptors in nociceptive neurons. Proc Natl Acad Sci U S A. 2008;105(43):16773–16778. doi:10.1073/pnas.0801793105
   PubMed Web of Science ®Google Scholar
• Xiang Z, Bo X, Burnstock G. Localization of ATP-gated P2X receptor immunoreactivity in rat sensory and sympathetic ganglia. Neurosci Lett. 1998;256(2):105–108. doi:10.1016/s0304-3940(98)00774-5
   PubMed Web of Science ®Google Scholar
• Dubový P, Jancálek R, Klusáková I, Svízenská I, Pejchalová K. Intra- and extraneuronal changes of immunofluorescence staining for TNF-alpha and TNFR1 in the dorsal root ganglia of rat peripheral neuropathic pain models. Cell Mol Neurobiol. 2006;26(7–8):1205–1217. doi:10.1007/s10571-006-9006-3
   PubMed Web of Science ®Google Scholar
• Jang Y, Kim M, Hwang SW. Molecular mechanisms underlying the actions of arachidonic acid-derived prostaglandins on peripheral nociception. J Neuroinflammation. 2020;17:30. doi:10.1186/s12974-020-1703-1
   PubMed Web of Science ®Google Scholar
• Ohtori S, Takahashi K, Moriya H, Myers RR. TNF-alpha and TNF-alpha receptor type 1 upregulation in glia and neurons after peripheral nerve injury: studies in murine DRG and spinal cord. Spine. 2004;29(10):1082–1088. doi:10.1097/00007632-200405150-00006
   PubMed Web of Science ®Google Scholar
• Jin X, Gereau RW. Acute p38-mediated modulation of tetrodotoxin-resistant sodium channels in mouse sensory neurons by tumor necrosis factor-alpha. J Neurosci. 2006;26(1):246–255. doi:10.1523/JNEUROSCI.3858-05.2006
   PubMed Web of Science ®Google Scholar
• Li M, Shi J, Tang JR, et al. Effects of complete Freund’s adjuvant on immunohistochemical distribution of IL-1beta and IL-1R I in neurons and glia cells of dorsal root ganglion. Acta Pharmacol Sin. 2005;26(2):192–198. doi:10.1111/j.1745-7254.2005.00522.x
   PubMed Web of Science ®Google Scholar
• Liu B, Li H, Brull SJ, Zhang JM. Increased sensitivity of sensory neurons to tumor necrosis factor alpha in rats with chronic compression of the lumbar ganglia. J Neurophysiol. 2002;88(3):1393–1399. doi:10.1152/jn.2002.88.3.1393
   PubMed Web of Science ®Google Scholar
• Dahl G, Qiu F, Wang J. The bizarre pharmacology of the ATP release channel pannexin1. Neuropharmacology. 2013;75:583–593. doi:10.1016/j.neuropharm.2013.02.019
   PubMed Web of Science ®Google Scholar
• Feldman-Goriachnik R, Belzer V, Hanani M. Systemic inflammation activates satellite glial cells in the mouse nodose ganglion and alters their functions. Glia. 2015;63(11):2121–2132. doi:10.1002/glia.22881
   PubMed Web of Science ®Google Scholar
• Hanstein R, Hanani M, Scemes E, Spray DC. Glial pannexin1 contributes to tactile hypersensitivity in a mouse model of orofacial pain. Sci Rep. 2016;6:38266. doi:10.1038/srep38266
   PubMed Web of Science ®Google Scholar
• Zhang Y, Laumet G, Chen SR, Hittelman WN, Pan HL. Pannexin-1 Up-regulation in the Dorsal Root Ganglion Contributes to Neuropathic Pain Development. J Biol Chem. 2015;290(23):14647–14655. doi:10.1074/jbc.M115.650218
   PubMed Web of Science ®Google Scholar
• Vit JP, Ohara PT, Bhargava A, Kelley K, Jasmin L. Silencing the Kir4.1 potassium channel subunit in satellite glial cells of the rat trigeminal ganglion results in pain-like behavior in the absence of nerve injury. J Neurosci. 2008;28(16):4161–4171. doi:10.1523/JNEUROSCI.5053-07.2008
   PubMed Web of Science ®Google Scholar
• Cherkas PS, Huang TY, Pannicke T, Tal M, Reichenbach A, Hanani M. The effects of axotomy on neurons and satellite glial cells in mouse trigeminal ganglion. Pain. 2004;110(1–2):290–298. doi:10.1016/j.pain.2004.04.007
   PubMed Web of Science ®Google Scholar
• Huang TY, Belzer V, Hanani M. Gap junctions in dorsal root ganglia: possible contribution to visceral pain. Eur J Pain. 2010;14(1):49.e1–11. doi:10.1016/j.ejpain.2009.02.005
   Web of Science ®Google Scholar
• Ledda M, Blum E, De Palo S, Hanani M. Augmentation in gap junction-mediated cell coupling in dorsal root ganglia following sciatic nerve neuritis in the mouse. Neuroscience. 2009;164(4):1538–1545. doi:10.1016/j.neuroscience.2009.09.038
   PubMed Web of Science ®Google Scholar
• Suadicani SO, Cherkas PS, Zuckerman J, Smith DN, Spray DC, Hanani M. Bidirectional calcium signaling between satellite glial cells and neurons in cultured mouse trigeminal ganglia. Neuron Glia Biol. 2010;6(1):43–51. doi:10.1017/S1740925X09990408
   PubMedGoogle Scholar
• Warwick RA, Hanani M. The contribution of satellite glial cells to chemotherapy-induced neuropathic pain. Eur J Pain. 2013;17(4):571–580. doi:10.1002/j.1532-2149.2012.00219.x
   PubMed Web of Science ®Google Scholar
• Warwick RA, Hanani M. Involvement of aberrant calcium signalling in herpetic neuralgia. Exp Neurol. 2016;277:10–18. doi:10.1016/j.expneurol.2015.12.002
   PubMed Web of Science ®Google Scholar
• Zhang H, Mei X, Zhang P, et al. Altered functional properties of satellite glial cells in compressed spinal ganglia. Glia. 2009;57(15):1588–1599. doi:10.1002/glia.20872
   PubMed Web of Science ®Google Scholar
• Ydens E, Amann L, Asselbergh B, et al. Profiling peripheral nerve macrophages reveals two macrophage subsets with distinct localization, transcriptome and response to injury. Nat Neurosci. 2020;23(5):676–689. doi:10.1038/s41593-020-0618-6
   PubMed Web of Science ®Google Scholar
• Zigmond RE, Echevarria FD. Macrophage biology in the peripheral nervous system after injury. Prog Neurobiol. 2019;173:102–121. doi:10.1016/j.pneurobio.2018.12.001
   PubMed Web of Science ®Google Scholar
• Peng J, Gu N, Zhou L, et al. Microglia and monocytes synergistically promote the transition from acute to chronic pain after nerve injury. Nat Commun. 2016;7:12029. doi:10.1038/ncomms12029
   PubMed Web of Science ®Google Scholar
• Domoto R, Sekiguchi F, Tsubota M, Kawabata A. Macrophage as a Peripheral Pain Regulator. Cells. 2021;10(8):1881. doi:10.3390/cells10081881
   PubMed Web of Science ®Google Scholar
• Geraghty T, Winter DR, Miller RJ, Miller RE, Malfait AM. Neuroimmune interactions and osteoarthritis pain: focus on macrophages. PR9. 2021;6(1):e892. doi:10.1097/PR9.0000000000000892
   Web of Science ®Google Scholar
• Siouti E, Andreakos E. The many facets of macrophages in rheumatoid arthritis. Biochem Pharmacol. 2019;165:152–169. doi:10.1016/j.bcp.2019.03.029
   PubMed Web of Science ®Google Scholar
• Udalova IA, Mantovani A, Feldmann M. Macrophage heterogeneity in the context of rheumatoid arthritis. Nat Rev Rheumatol. 2016;12(8):472–485. doi:10.1038/nrrheum.2016.91
   PubMed Web of Science ®Google Scholar
• Gerlag DM, Tak PP. Novel approaches for the treatment of rheumatoid arthritis: lessons from the evaluation of synovial biomarkers in clinical trials. Best Pract Res Clin Rheumatol. 2008;22(2):311–323. doi:10.1016/j.berh.2008.02.002
   PubMed Web of Science ®Google Scholar
• Wu CL, Harasymowicz NS, Klimak MA, Collins KH, Guilak F. The role of macrophages in osteoarthritis and cartilage repair. Osteoarthritis Cartilage. 2020;28(5):544–554. doi:10.1016/j.joca.2019.12.007
   PubMed Web of Science ®Google Scholar
• Zhang H, Cai D, Bai X. Macrophages regulate the progression of osteoarthritis. Osteoarthritis Cartilage. 2020;28(5):555–561. doi:10.1016/j.joca.2020.01.007
   PubMed Web of Science ®Google Scholar
• Sekiguchi F, Domoto R, Nakashima K, et al. Paclitaxel-induced HMGB1 release from macrophages and its implication for peripheral neuropathy in mice: evidence for a neuroimmune crosstalk. Neuropharmacology. 2018;141:201–213. doi:10.1016/j.neuropharm.2018.08.040
   PubMed Web of Science ®Google Scholar
• Sekiguchi F, Kawabata A. Role of HMGB1 in Chemotherapy-Induced Peripheral Neuropathy. Int J Mol Sci. 2020;22(1):E367. doi:10.3390/ijms22010367
   PubMed Web of Science ®Google Scholar
• Tsujita R, Tsubota M, Sekiguchi F, Kawabata A. Role of high-mobility group box 1 and its modulation by thrombomodulin/thrombin axis in neuropathic and inflammatory pain. Br J Pharmacol. 2021;178(4):798–812. doi:10.1111/bph.15091
   PubMed Web of Science ®Google Scholar
• Kotaka M, Saito Y, Kato T, et al. A placebo-controlled, double-blind, randomized study of recombinant thrombomodulin (ART-123) to prevent oxaliplatin-induced peripheral neuropathy. Cancer Chemother Pharmacol. 2020;86(5):607–618. doi:10.1007/s00280-020-04135-8
   PubMed Web of Science ®Google Scholar
• Oliveira-Fusaro MC, Gregory NS, Kolker SJ, Rasmussen L, Allen LAH, Sluka KA. P2X4 Receptors on Muscle Macrophages Are Required for Development of Hyperalgesia in an Animal Model of Activity-Induced Muscle Pain. Mol Neurobiol. 2020;57(4):1917–1929. doi:10.1007/s12035-019-01852-x
   PubMed Web of Science ®Google Scholar
• Ulmann L, Hirbec H, Rassendren F. P2X4 receptors mediate PGE2 release by tissue-resident macrophages and initiate inflammatory pain. EMBO J. 2010;29(14):2290–2300. doi:10.1038/emboj.2010.126
   PubMed Web of Science ®Google Scholar
• Junger WG. Immune cell regulation by autocrine purinergic signalling. Nat Rev Immunol. 2011;11(3):201–212. doi:10.1038/nri2938
   PubMed Web of Science ®Google Scholar
• Lucrezi JD, Burns TJ, Matesic DF, Oldham CD, May SW. Inhibition of JNK and p38 MAPK phosphorylation by 5-(acetylamino)-4-oxo-6-phenyl-2-hexenoic acid methyl ester and 4-phenyl-butenoic acid decreases substance P-induced TNF-α upregulation in macrophages. Int Immunopharmacol. 2014;21(1):44–50. doi:10.1016/j.intimp.2014.04.007
   PubMed Web of Science ®Google Scholar
• Sun J, Ramnath RD, Zhi L, Tamizhselvi R, Bhatia M. Substance P enhances NF-κB transactivation and chemokine response in murine macrophages via ERK1/2 and p38 MAPK signaling pathways. Am J Physiol Cell Physiol. 2008;294(6):C1586–C1596. doi:10.1152/ajpcell.00129.2008
   PubMed Web of Science ®Google Scholar
• Kwon MJ, Shin HY, Cui Y, et al. CCL2 Mediates Neuron-Macrophage Interactions to Drive Proregenerative Macrophage Activation Following Preconditioning Injury. J Neurosci. 2015;35(48):15934–15947. doi:10.1523/JNEUROSCI.1924-15.2015
   PubMed Web of Science ®Google Scholar
• Huang ZZ, Li D, Liu CC, et al. CX3CL1-mediated macrophage activation contributed to paclitaxel-induced DRG neuronal apoptosis and painful peripheral neuropathy. Brain Behav Immun. 2014;40:155–165. doi:10.1016/j.bbi.2014.03.014
   PubMed Web of Science ®Google Scholar
• Simeoli R, Montague K, Jones HR, et al. Exosomal cargo including microRNA regulates sensory neuron to macrophage communication after nerve trauma. Nat Commun. 2017;8(1):1778. doi:10.1038/s41467-017-01841-5
   PubMed Web of Science ®Google Scholar
• van der Vlist M, Raoof R, Willemen HLDM, et al. Macrophages transfer mitochondria to sensory neurons to resolve inflammatory pain. Neuron. 2022;110(4):613–626.e9. doi:10.1016/j.neuron.2021.11.020
   PubMed Web of Science ®Google Scholar
• Chen O, Donnelly CR, Ji RR. Regulation of pain by neuro-immune interactions between macrophages and nociceptor sensory neurons. Curr Opin Neurobiol. 2020;62:17–25. doi:10.1016/j.conb.2019.11.006
   PubMed Web of Science ®Google Scholar
• Ebbinghaus M, Uhlig B, Richter F, et al. The role of interleukin-1β in arthritic pain: main involvement in thermal, but not mechanical, hyperalgesia in rat antigen-induced arthritis. Arthritis Rheum. 2012;64(12):3897–3907. doi:10.1002/art.34675
   PubMed Web of Science ®Google Scholar
• Jeevakumar V, Al Sardar AK, Mohamed F, Smithhart CM, Price T, Dussor G. IL-6 induced upregulation of T-type Ca2+ currents and sensitization of DRG nociceptors is attenuated by MNK inhibition. J Neurophysiol. 2020;124(1):274–283. doi:10.1152/jn.00188.2020
   PubMed Web of Science ®Google Scholar
• Ma W, St-Jacques B, Duarte PC. Targeting pain mediators induced by injured nerve-derived COX2 and PGE2 to treat neuropathic pain. Expert Opin Ther Targets. 2012;16(6):527–540. doi:10.1517/14728222.2012.680955
   PubMed Web of Science ®Google Scholar
• Dilek N, Papapetropoulos A, Toliver-Kinsky T, Szabo C. Hydrogen sulfide: an endogenous regulator of the immune system. Pharmacol Res. 2020;161:105119. doi:10.1016/j.phrs.2020.105119
   PubMed Web of Science ®Google Scholar
• Kawabata A, Ishiki T, Nagasawa K, et al. Hydrogen sulfide as a novel nociceptive messenger. Pain. 2007;132(1–2):74–81. doi:10.1016/j.pain.2007.01.026
   PubMed Web of Science ®Google Scholar
• Terada Y, Fujimura M, Nishimura S, Tsubota M, Sekiguchi F, Kawabata A. Roles of Cav3.2 and TRPA1 channels targeted by hydrogen sulfide in pancreatic nociceptive processing in mice with or without acute pancreatitis. J Neurosci Res. 2015;93(2):361–369. doi:10.1002/jnr.23490
   PubMed Web of Science ®Google Scholar
• Labuz D, Celik MÖ, Seitz V, Machelska H. Interleukin-4 Induces the Release of Opioid Peptides from M1 Macrophages in Pathological Pain. J Neurosci. 2021;41(13):2870–2882. doi:10.1523/JNEUROSCI.3040-20.2021
   PubMed Web of Science ®Google Scholar
• Shen KF, Zhu HQ, Wei XH, et al. Interleukin-10 down-regulates voltage gated sodium channels in rat dorsal root ganglion neurons. Exp Neurol. 2013;247:466–475. doi:10.1016/j.expneurol.2013.01.018
   PubMed Web of Science ®Google Scholar
• Rossi-Semerano L, Fautrel B, Wendling D, et al. Tolerance and efficacy of off-label anti-interleukin-1 treatments in France: a nationwide survey. Orphanet J Rare Dis. 2015;10(1):19. doi:10.1186/s13023-015-0228-7
   PubMed Web of Science ®Google Scholar
• Tan AL, Marzo-Ortega H, O’Connor P, Fraser A, Emery P, McGonagle D. Efficacy of anakinra in active ankylosing spondylitis: a clinical and magnetic resonance imaging study. Ann Rheum Dis. 2004;63(9):1041–1045. doi:10.1136/ard.2004.020800
   PubMed Web of Science ®Google Scholar
• Federici S, Martini A, Gattorno M. The Central Role of Anti-IL-1 Blockade in the Treatment of Monogenic and Multi-Factorial Autoinflammatory Diseases. Front Immunol. 2013;4:351. doi:10.3389/fimmu.2013.00351
   PubMed Web of Science ®Google Scholar
• Kalliolias GD, Liossis C. The future of the IL-1 receptor antagonist anakinra: from rheumatoid arthritis to adult-onset Still’s disease and systemic-onset juvenile idiopathic arthritis. Expert Opin Investig Drugs. 2008;17(3):349–359. doi:10.1517/13543784.17.3.349
   PubMed Web of Science ®Google Scholar
• McGonagle D, Tan AL, Shankaranarayana S, Madden J, Emery P, McDermott MF. Management of treatment resistant inflammation of acute on chronic tophaceous gout with anakinra. Ann Rheum Dis. 2007;66(12):1683–1684. doi:10.1136/ard.2007.073759
   PubMed Web of Science ®Google Scholar
• Saag KG, Khanna PP, Keenan RT, et al. A Randomized, Phase II Study Evaluating the Efficacy and Safety of Anakinra in the Treatment of Gout Flares. Arthritis Rheumatol. 2021;73(8):1533–1542. doi:10.1002/art.41699
   PubMed Web of Science ®Google Scholar
• Terkeltaub R, Sundy JS, Schumacher HR, et al. The interleukin 1 inhibitor rilonacept in treatment of chronic gouty arthritis: results of a placebo-controlled, monosequence crossover, non-randomised, single-blind pilot study. Ann Rheum Dis. 2009;68(10):1613–1617. doi:10.1136/ard.2009.108936
   PubMed Web of Science ®Google Scholar
• Bresnihan B, Cobby M. Clinical and radiological effects of anakinra in patients with rheumatoid arthritis. Rheumatology. 2003;42(Suppl 2):ii22–28. doi:10.1093/rheumatology/keg329
   PubMed Web of Science ®Google Scholar
• Furst DE. Anakinra: review of recombinant human interleukin-I receptor antagonist in the treatment of rheumatoid arthritis. Clin Ther. 2004;26(12):1960–1975. doi:10.1016/j.clinthera.2004.12.019
   PubMed Web of Science ®Google Scholar
• Nikfar S, Saiyarsarai P, Tigabu BM, Abdollahi M. Efficacy and safety of interleukin-1 antagonists in rheumatoid arthritis: a systematic review and meta-analysis. Rheumatol Int. 2018;38(8):1363–1383. doi:10.1007/s00296-018-4041-1
   PubMed Web of Science ®Google Scholar
• Kraus VB, Birmingham J, Stabler TV, et al. Effects of intraarticular IL1-Ra for acute anterior cruciate ligament knee injury: a randomized controlled pilot trial (NCT00332254). Osteoarthritis Cartilage. 2012;20(4):271–278. doi:10.1016/j.joca.2011.12.009
   PubMed Web of Science ®Google Scholar
• Helyes Z, Tékus V, Szentes N, et al. Transfer of complex regional pain syndrome to mice via human autoantibodies is mediated by interleukin-1–induced mechanisms. PNAS. 2019;116(26):13067–13076. doi:10.1073/pnas.1820168116
   PubMed Web of Science ®Google Scholar
• Callhoff J, Sieper J, Weiß A, Zink A, Listing J. Efficacy of TNFα blockers in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: a meta-analysis. Ann Rheum Dis. 2015;74(6):1241–1248. doi:10.1136/annrheumdis-2014-205322
   PubMed Web of Science ®Google Scholar
• Czókolyová M, Pusztai A, Végh E, et al. Changes of Metabolic Biomarker Levels upon One-Year Anti-TNF-α Therapy in Rheumatoid Arthritis and Ankylosing Spondylitis: associations with Vascular Pathophysiology. Biomolecules. 2021;11(10):1535. doi:10.3390/biom11101535
   PubMed Web of Science ®Google Scholar
• Ferrari M, Onuoha SC, Fossati-Jimack L, et al. Novel Bispecific Antibody for Synovial-Specific Target Delivery of Anti-TNF Therapy in Rheumatoid Arthritis. Front Immunol. 2021;12:640070. doi:10.3389/fimmu.2021.640070
   PubMed Web of Science ®Google Scholar
• Mantravadi S, Ogdie A, Kraft WK. Tumor necrosis factor inhibitors in psoriatic arthritis. Expert Rev Clin Pharmacol. 2017;10(8):899–910. doi:10.1080/17512433.2017.1329009
   PubMed Web of Science ®Google Scholar
• Papamichael K, Lin S, Moore M, Papaioannou G, Sattler L, Cheifetz AS. Infliximab in inflammatory bowel disease. Ther Adv Chronic Dis. 2019;10:2040622319838443. doi:10.1177/2040622319838443
   Web of Science ®Google Scholar
• Shim MR. Efficacy of TNF inhibitors in advanced ankylosing spondylitis with total spinal fusion: case report and review of literature. OARRR. 2019;11:173–177. doi:10.2147/OARRR.S212456
   Web of Science ®Google Scholar
• Breedveld FC, Weisman MH, Kavanaugh AF, et al. The PREMIER study: a multicenter, randomized, double-blind clinical trial of combination therapy with Adalimumab plus methotrexate versus methotrexate alone or Adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment. Arthritis Rheum. 2006;54(1):26–37. doi:10.1002/art.21519
   PubMed Web of Science ®Google Scholar
• Klareskog L, van der Heijde D, de Jager JP, et al. Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial. Lancet. 2004;363(9410):675–681. doi:10.1016/S0140-6736(04)
   PubMed Web of Science ®Google Scholar
• Sfikakis PP. The first decade of biologic TNF antagonists in clinical practice: lessons learned, unresolved issues and future directions. Curr Dir Autoimmun. 2010;11:180–210. doi:10.1159/000289205
   PubMedGoogle Scholar
• Freeman BJC, Ludbrook GL, Hall S, et al. Randomized, double-blind, placebo-controlled, trial of transforaminal epidural etanercept for the treatment of symptomatic lumbar disc herniation. Spine. 2013;38(23):1986–1994. doi:10.1097/01.brs.0000435140.61593.4c
   PubMed Web of Science ®Google Scholar
• Okoro T, Tafazal SI, Longworth S, Sell PJ. Tumor necrosis alpha-blocking agent (etanercept): a triple blind randomized controlled trial of its use in treatment of sciatica. J Spinal Disord Tech. 2010;23(1):74–77. doi:10.1097/BSD.0b013e31819afdc4
   PubMed Web of Science ®Google Scholar
• Pimentel DC, El Abd O, Benyamin RM, et al. Anti-tumor necrosis factor antagonists in the treatment of low back pain and radiculopathy: a systematic review and meta-analysis. Pain Physician. 2014;17(1):E27–44.
   PubMed Web of Science ®Google Scholar
• Tobinick E. Perispinal etanercept: a new therapeutic paradigm in neurology. Expert Rev Neurother. 2010;10(6):985–1002. doi:10.1586/ern.10.52
   PubMed Web of Science ®Google Scholar
• Ahmed R, Soliman N. Serum interleukin-6 in primary fibromyalgia syndrome patients: impact on disease burden, severity, quality of life and sleep. Egyptian Rheumatologist. 2022;44(1):15–18. doi:10.1016/j.ejr.2021.07.004
   Web of Science ®Google Scholar
• Karshikoff B, Martucci KT, Mackey S. Relationship Between Blood Cytokine Levels, Psychological Comorbidity, and Widespreadness of Pain in Chronic Pelvic Pain. Front Psychiatry. 2021;12:548.
   Web of Science ®Google Scholar
• Sebba A. Pain: a Review of Interleukin-6 and Its Roles in the Pain of Rheumatoid Arthritis. OARRR. 2021;13:31–43. doi:10.2147/OARRR.S291388
   Web of Science ®Google Scholar
• Teodorczyk-Injeyan JA, Triano JJ, Injeyan HS. Nonspecific Low Back Pain: inflammatory Profiles of Patients With Acute and Chronic Pain. Clin J Pain. 2019;35(10):818–825. doi:10.1097/AJP.0000000000000745
   PubMed Web of Science ®Google Scholar
• Zhou YQ, Liu Z, Liu ZH, et al. Interleukin-6: an emerging regulator of pathological pain. J Neuroinflammation. 2016;13:141. doi:10.1186/s12974-016-0607-6
   PubMed Web of Science ®Google Scholar
• Emery P, Rondon J, Parrino J, et al. Safety and tolerability of subcutaneous sarilumab and intravenous tocilizumab in patients with rheumatoid arthritis. Rheumatology. 2019;58(5):849–858. doi:10.1093/rheumatology/key361
   PubMed Web of Science ®Google Scholar
• Fleischmann R, Genovese MC, Lin Y, et al. Long-term safety of sarilumab in rheumatoid arthritis: an integrated analysis with up to 7 years’ follow-up. Rheumatology. 2020;59(2):292–302. doi:10.1093/rheumatology/kez265
   PubMed Web of Science ®Google Scholar
• Hoffman E, Rahat MA, Feld J, et al. Effects of Tocilizumab, an Anti-Interleukin-6 Receptor Antibody, on Serum Lipid and Adipokine Levels in Patients with Rheumatoid Arthritis. IJMS. 2019;20(18):4633. doi:10.3390/ijms20184633
   Web of Science ®Google Scholar
• Ohtori S, Miyagi M, Eguchi Y, et al. Efficacy of epidural administration of anti-interleukin-6 receptor antibody onto spinal nerve for treatment of sciatica. Eur Spine J. 2012;21(10):2079–2084. doi:10.1007/s00586-012-2183-5
   PubMed Web of Science ®Google Scholar
• Sainoh T, Orita S, Miyagi M, et al. Single intradiscal injection of the interleukin-6 receptor antibody tocilizumab provides short-term relief of discogenic low back pain; prospective comparative cohort study. J Orthopaedic Sci. 2016;21(1):2–6. doi:10.1016/j.jos.2015.10.005
   PubMed Web of Science ®Google Scholar
• Sainoh T, Orita S, Miyagi M, et al. Improvements in Intractable Lumbar and LowerExtremity Symptoms after Systemic Administration of Tocilizumab, an Anti-interleukin-6 Receptor Antibody. Asian Spine J. 2021. doi:10.31616/asj.2020.0283
   PubMed Web of Science ®Google Scholar
• Lassen LH, Haderslev PA, Jacobsen VB, Iversen HK, Sperling B, Olesen J. CGRP may play a causative role in migraine. Cephalalgia. 2002;22(1):54–61. doi:10.1046/j.1468-2982.2002.00310.x
   PubMed Web of Science ®Google Scholar
• Dodick DW, Ashina M, Brandes JL, et al. ARISE: a Phase 3 randomized trial of erenumab for episodic migraine. Cephalalgia. 2018;38(6):1026–1037. doi:10.1177/0333102418759786
   PubMed Web of Science ®Google Scholar
• Goadsby PJ, Reuter U, Hallström Y, et al. A Controlled Trial of Erenumab for Episodic Migraine. N Engl J Med. 2017;377(22):2123–2132. doi:10.1056/NEJMoa1705848
   PubMed Web of Science ®Google Scholar
• Tepper S, Ashina M, Reuter U, et al. Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial. Lancet Neurol. 2017;16(6):425–434. doi:10.1016/S1474-4422(17)
   PubMed Web of Science ®Google Scholar
• Traynor K. FDA approves licensing of erenumab-aooe to prevent migraine. Am J Health Syst Pharm. 2018;75(13):929–930. doi:10.2146/news180044
   Web of Science ®Google Scholar
• Biohaven Pharmaceuticals, Inc. BHV3000-202: phase 2: a Double-Blind, Placebo Controlled, Crossover Trial of BHV-3000 (Rimegepant) for Treatment Refractory Trigeminal Neuraligia. 2021. Available from: https://clinicaltrials.gov/ct2/show/NCT03941834. Accessed February 3, 2022.
   Google Scholar
• Jonzon MD. A Placebo-Controlled, Double-Blind, Randomized, Proof-of-Concept Study to Evaluate the Efficacy and Tolerability of Erenumab in Patients With Trigeminal Neuralgia. 2019. Available from: https://clinicaltrials.gov/ct2/show/NCT04054024. Accessed February 3, 2022.
   Google Scholar
• Teva Branded Pharmaceutical Products R&D, Inc. A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Proof of Concept Study of the Efficacy and Safety of Fremanezumab for Treatment of Patients With Fibromyalgia; 2021. Available from: https://clinicaltrials.gov/ct2/show/NCT03965091. Accessed February 3, 2022.
   Google Scholar
• Kalliomäki J, Attal N, Jonzon B, et al. A randomized, double-blind, placebo-controlled trial of a chemokine receptor 2 (CCR2) antagonist in posttraumatic neuralgia. Pain. 2013;154(5):761–767. doi:10.1016/j.pain.2013.02.003
   PubMed Web of Science ®Google Scholar
• Monnet E, Choy EH, McInnes I, et al. Efficacy and safety of NI-0101, an anti-toll-like receptor 4 monoclonal antibody, in patients with rheumatoid arthritis after inadequate response to methotrexate: a phase II study. Ann Rheum Dis. 2020;79(3):316–323. doi:10.1136/annrheumdis-2019-216487
   PubMed Web of Science ®Google Scholar
• Keystone EC, Wang MM, Layton M, Hollis S, McInnes IB. D1520C00001 Study Team. Clinical evaluation of the efficacy of the P2X7 purinergic receptor antagonist AZD9056 on the signs and symptoms of rheumatoid arthritis in patients with active disease despite treatment with methotrexate or sulphasalazine. Ann Rheum Dis. 2012;71(10):1630–1635. doi:10.1136/annrheumdis-2011-143578
   PubMed Web of Science ®Google Scholar
• Garrido-Mesa N, Zarzuelo A, Gálvez J. Minocycline: far beyond an antibiotic. Br J Pharmacol. 2013;169(2):337–352. doi:10.1111/bph.12139
   PubMed Web of Science ®Google Scholar
• Sapadin AN, Fleischmajer R. Tetracyclines: nonantibiotic properties and their clinical implications. J Am Acad Dermatol. 2006;54(2):258–265. doi:10.1016/j.jaad.2005.10.004
   PubMed Web of Science ®Google Scholar
• Tikka TM, Koistinaho JE. Minocycline provides neuroprotection against N-methyl-D-aspartate neurotoxicity by inhibiting microglia. J Immunol. 2001;166(12):7527–7533. doi:10.4049/jimmunol.166.12.7527
   PubMed Web of Science ®Google Scholar
• Hains BC, Waxman SG. Activated microglia contribute to the maintenance of chronic pain after spinal cord injury. J Neurosci. 2006;26(16):4308–4317. doi:10.1523/JNEUROSCI.0003-06.2006
   PubMed Web of Science ®Google Scholar
• Owolabi SA, Saab CY. Fractalkine and minocycline alter neuronal activity in the spinal cord dorsal horn. FEBS Lett. 2006;580(18):4306–4310. doi:10.1016/j.febslet.2006.06.087
   PubMed Web of Science ®Google Scholar
• Martinez V, Szekely B, Lemarié J, et al. The efficacy of a glial inhibitor, minocycline, for preventing persistent pain after lumbar discectomy: a randomized, double-blind, controlled study. Pain. 2013;154(8):1197–1203. doi:10.1016/j.pain.2013.03.028
   PubMed Web of Science ®Google Scholar
• Vanelderen P, Van Zundert J, Kozicz T, et al. Effect of minocycline on lumbar radicular neuropathic pain: a randomized, placebo-controlled, double-blind clinical trial with amitriptyline as a comparator. Anesthesiology. 2015;122(2):399–406. doi:10.1097/ALN.0000000000000508
   PubMed Web of Science ®Google Scholar
• Curtin CM, Kenney D, Suarez P, et al. A Double-Blind Placebo Randomized Controlled Trial of Minocycline to Reduce Pain After Carpal Tunnel and Trigger Finger Release. J Hand Surg Am. 2017;42(3):166–174. doi:10.1016/j.jhsa.2016.12.011
   PubMed Web of Science ®Google Scholar
• Syngle A, Verma I, Krishan P, Garg N, Syngle V. Minocycline improves peripheral and autonomic neuropathy in type 2 diabetes: MIND study. Neurol Sci. 2014;35(7):1067–1073. doi:10.1007/s10072-014-1647-2
   PubMed Web of Science ®Google Scholar
• Möller T, Bard F, Bhattacharya A, et al. Critical data-based re-evaluation of minocycline as a putative specific microglia inhibitor. Glia. 2016;64(10):1788–1794. doi:10.1002/glia.23007
   PubMed Web of Science ®Google Scholar
• DeLeo J, Toth L, Schubert P, Rudolphi K, Kreutzberg GW. Ischemia-induced neuronal cell death, calcium accumulation, and glial response in the hippocampus of the Mongolian gerbil and protection by propentofylline (HWA 285). J Cereb Blood Flow Metab. 1987;7(6):745–751. doi:10.1038/jcbfm.1987.129
   PubMed Web of Science ®Google Scholar
• Tawfik VL, Nutile-McMenemy N, LaCroix-Fralish ML, DeLeo JA. Efficacy of propentofylline, a glial modulating agent, on existing mechanical allodynia following peripheral nerve injury. Brain Behav Immun. 2007;21(2):238–246. doi:10.1016/j.bbi.2006.07.001
   PubMed Web of Science ®Google Scholar
• Landry RP, Jacobs VL, Romero-Sandoval EA, DeLeo JA. Propentofylline, a CNS glial modulator does not decrease pain in post-herpetic neuralgia patients: in vitro evidence for differential responses in human and rodent microglia and macrophages. Exp Neurol. 2012;234(2):340–350. doi:10.1016/j.expneurol.2011.11.006
   PubMed Web of Science ®Google Scholar
• Mizuno T, Kurotani T, Komatsu Y, et al. Neuroprotective role of phosphodiesterase inhibitor ibudilast on neuronal cell death induced by activated microglia. Neuropharmacology. 2004;46(3):404–411. doi:10.1016/j.neuropharm.2003.09.009
   PubMed Web of Science ®Google Scholar
• Kwok YH, Swift JE, Gazerani P, Rolan P. A double-blind, randomized, placebo-controlled pilot trial to determine the efficacy and safety of ibudilast, a potential glial attenuator, in chronic migraine. J Pain Res. 2016;9:899–907. doi:10.2147/JPR.S116968
   PubMed Web of Science ®Google Scholar
• Johnson JL, Kwok YH, Sumracki NM, et al. Glial Attenuation With Ibudilast in the Treatment of Medication Overuse Headache: a Double-Blind, Randomized, Placebo-Controlled Pilot Trial of Efficacy and Safety. Headache. 2015;55(9):1192–1208. doi:10.1111/head.12655
   PubMed Web of Science ®Google Scholar
• Rolan P, Hutchinson M, Johnson K. Ibudilast: a review of its pharmacology, efficacy and safety in respiratory and neurological disease. Expert Opin Pharmacother. 2009;10(17):2897–2904. doi:10.1517/14656560903426189
   PubMed Web of Science ®Google Scholar
• Metz VE, Jones JD, Manubay J, et al. Effects of Ibudilast on the Subjective, Reinforcing, and Analgesic Effects of Oxycodone in Recently Detoxified Adults with Opioid Dependence. Neuropsychopharmacol. 2017;42(9):1825–1832. doi:10.1038/npp.2017.70
   PubMed Web of Science ®Google Scholar
• Burnette EM, Baskerville WA, Grodin EN, Ray LA. Ibudilast for alcohol use disorder: study protocol for a phase II randomized clinical trial. Trials. 2020;21:779. doi:10.1186/s13063-020-04670-y
   PubMed Web of Science ®Google Scholar
• Grodin EN, Bujarski S, Towns B, et al. Ibudilast, a neuroimmune modulator, reduces heavy drinking and alcohol cue-elicited neural activation: a randomized trial. Transl Psychiatry. 2021;11(1):355. doi:10.1038/s41398-021-01478-5
   PubMed Web of Science ®Google Scholar
• Eker HE, Cok OY, Aribogan A, Arslan G. Management of neuropathic pain with methylprednisolone at the site of nerve injury. Pain Med. 2012;13(3):443–451. doi:10.1111/j.1526-4637.2011.01323.x
   PubMed Web of Science ®Google Scholar
• Kotani N, Kushikata T, Hashimoto H, et al. Intrathecal methylprednisolone for intractable postherpetic neuralgia. N Engl J Med. 2000;343(21):1514–1519. doi:10.1056/NEJM200011233432102
   PubMed Web of Science ®Google Scholar
• Riew KD, Yin Y, Gilula L, et al. The effect of nerve-root injections on the need for operative treatment of lumbar radicular pain. A prospective, randomized, controlled, double-blind study. J Bone Joint Surg Am. 2000;82(11):1589–1593. doi:10.2106/00004623-200011000-00012
   PubMed Web of Science ®Google Scholar
• Friedly J, Chan L, Deyo R. Increases in lumbosacral injections in the Medicare population: 1994 to 2001. Spine. 2007;32(16):1754–1760. doi:10.1097/BRS.0b013e3180b9f96e
   PubMed Web of Science ®Google Scholar
• Friedly JL, Comstock BA, Turner JA, et al. A Randomized Trial of Epidural Glucocorticoid Injections for Spinal Stenosis. N Eng J Med. 2014;371(1):11–21. doi:10.1056/NEJMoa1313265
   PubMed Web of Science ®Google Scholar
• Manchikanti L, Singh V, Pampati V, Smith HS, Hirsch JA. Analysis of growth of interventional techniques in managing chronic pain in the Medicare population: a 10-year evaluation from 1997 to 2006. Pain Physician. 2009;12(1):9–34.
   PubMed Web of Science ®Google Scholar
• Botwin KP, Gruber RD, Bouchlas CG, et al. Fluoroscopically guided lumbar transformational epidural steroid injections in degenerative lumbar stenosis: an outcome study. Am J Phys Med Rehabil. 2002;81(12):898–905. doi:10.1097/00002060-200212000-00003
   PubMed Web of Science ®Google Scholar
• Ciocon JO, Galindo-Ciocon D, Amaranath L, Galindo D. Caudal epidural blocks for elderly patients with lumbar canal stenosis. J Am Geriatr Soc. 1994;42(6):593–596. doi:10.1111/j.1532-5415.1994.tb06855.x
   PubMed Web of Science ®Google Scholar
• Hashemi M, Dadkhah P, Taheri M, Ghasemi M, Hosseinpour A. Lumbar Transforaminal Epidural Steroid Injection in Patients with Lumbar Radicular Pain; Outcome Results of 2-Year Follow-Up. Bull Emerg Trauma. 2019;7(2):144–149. doi:10.29252/beat-070209
   PubMedGoogle Scholar
• Klessinger S. Diagnostic Value of Transforaminal Injections of Steroids in Recurrent Disc Herniations. Spine Neurosurgery. 2014;2013:548.
   Google Scholar
• Smith CC, McCormick ZL, Mattie R, MacVicar J, Duszynski B, Stojanovic MP. The Effectiveness of Lumbar Transforaminal Injection of Steroid for the Treatment of Radicular Pain: a Comprehensive Review of the Published Data. Pain Med. 2020;21(3):472–487. doi:10.1093/pm/pnz160
   PubMed Web of Science ®Google Scholar
• Johansson A, Bennett GJ. Effect of local methylprednisolone on pain in a nerve injury model. A pilot study. Reg Anesth. 1997;22(1):59–65. doi:10.1016/s1098-7339(06)80057-x
   PubMedGoogle Scholar
• Li H, Xie W, Strong JA, Zhang JM. Systemic antiinflammatory corticosteroid reduces mechanical pain behavior, sympathetic sprouting, and elevation of proinflammatory cytokines in a rat model of neuropathic pain. Anesthesiology. 2007;107(3):469–477. doi:10.1097/01.anes.0000278907.37774.8d
   PubMed Web of Science ®Google Scholar
• Takeda K, Sawamura S, Sekiyama H, Tamai H, Hanaoka K. Effect of methylprednisolone on neuropathic pain and spinal glial activation in rats. Anesthesiology. 2004;100(5):1249–1257. doi:10.1097/00000542-200405000-00029
   PubMed Web of Science ®Google Scholar
• Ammendolia C, Stuber K, de Bruin LK, et al. Nonoperative treatment of lumbar spinal stenosis with neurogenic claudication: a systematic review. Spine. 2012;37(10):E609–616. doi:10.1097/BRS.0b013e318240d57d
   PubMed Web of Science ®Google Scholar
• Dong F, Xie W, Strong JA, Zhang JM. Mineralocorticoid receptor blocker eplerenone reduces pain behaviors in vivo and decreases excitability in small-diameter sensory neurons from local inflamed dorsal root ganglia in vitro. Anesthesiology. 2012;117(5):1102–1112. doi:10.1097/ALN.0b013e3182700383
   PubMed Web of Science ®Google Scholar
• Ibrahim SIA, Xie W, Strong JA, Tonello R, Berta T, Zhang JM. Mineralocorticoid Antagonist Improves Glucocorticoid Receptor Signaling and Dexamethasone Analgesia in an Animal Model of Low Back Pain. Front Cell Neurosci. 2018;12:453. doi:10.3389/fncel.2018.00453
   PubMed Web of Science ®Google Scholar
• Joëls M, Karst H, DeRijk R, de Kloet ER. The coming out of the brain mineralocorticoid receptor. Trends Neurosci. 2008;31(1):1–7. doi:10.1016/j.tins.2007.10.005
   PubMed Web of Science ®Google Scholar
• Ye L, Xie W, Strong JA, Zhang JM. Blocking the mineralocorticoid receptor improves effectiveness of steroid treatment for low back pain in rats. Anesthesiology. 2014;121(3):632–643. doi:10.1097/ALN.0000000000000277
   PubMed Web of Science ®Google Scholar
• Knotkova H, Hamani C, Sivanesan E, et al. Neuromodulation for chronic pain. Lancet. 2021;397(10289):2111–2124. doi:10.1016/S0140-6736(21)
   PubMed Web of Science ®Google Scholar
• Caylor J, Reddy R, Yin S, et al. Spinal cord stimulation in chronic pain: evidence and theory for mechanisms of action. Bioelectronic Med. 2019;5(1):12. doi:10.1186/s42234-019-0023-1
   PubMedGoogle Scholar
• Deer T, Slavin KV, Amirdelfan K, et al. Success Using Neuromodulation With BURST (SUNBURST) Study: results From a Prospective, Randomized Controlled Trial Using a Novel Burst Waveform. Neuromodulation. 2018;21(1):56–66. doi:10.1111/ner.12698
   PubMed Web of Science ®Google Scholar
• Kapural L, Yu C, Doust MW, et al. Novel 10-kHz High-frequency Therapy (HF10 Therapy) Is Superior to Traditional Low-frequency Spinal Cord Stimulation for the Treatment of Chronic Back and Leg Pain: the SENZA-RCT Randomized Controlled Trial. Anesthesiology. 2015;123(4):851–860. doi:10.1097/ALN.0000000000000774
   PubMed Web of Science ®Google Scholar
• Kemler MA, De Vet HCW, Barendse GAM, Van Den Wildenberg FAJM, Van Kleef M. The Effect of Spinal Cord Stimulation in Patients with Chronic Reflex Sympathetic Dystrophy: two Years’ Follow-up of the Randomized Controlled Trial. Ann Neurol. 2004;55(1):13–18. doi:10.1002/ana.10996
   PubMed Web of Science ®Google Scholar
• Kumar K, Taylor RS, Jacques L, et al. Spinal cord stimulation versus conventional medical management for neuropathic pain: a multicentre randomised controlled trial in patients with failed back surgery syndrome. Pain. 2007;132(1):179–188. doi:10.1016/j.pain.2007.07.028
   PubMed Web of Science ®Google Scholar
• Petersen EA, Stauss TG, Scowcroft JA, et al. Effect of High-frequency (10-kHz) Spinal Cord Stimulation in Patients With Painful Diabetic Neuropathy: a Randomized Clinical Trial. JAMA Neurol. 2021;78(6):687–698. doi:10.1001/jamaneurol.2021.0538
   PubMed Web of Science ®Google Scholar
• Vallejo R, Tilley DM, Cedeño DL, Kelley CA, DeMaegd M, Benyamin R. Genomics of the Effect of Spinal Cord Stimulation on an Animal Model of Neuropathic Pain. Neuromodulation. 2016;19(6):576–586. doi:10.1111/ner.12465
   PubMed Web of Science ®Google Scholar
• Sato KL, Johanek LM, Sanada LS, Sluka KA. Spinal cord stimulation reduces mechanical hyperalgesia and glial cell activation in animals with neuropathic pain. Anesth Analg. 2014;118(2):464–472. doi:10.1213/ANE.0000000000000047
   PubMed Web of Science ®Google Scholar
• Sivanesan E, Stephens KE, Huang Q, et al. Spinal cord stimulation prevents paclitaxel-induced mechanical and cold hypersensitivity and modulates spinal gene expression in rats. Pain Rep. 2019;4(5):e785. doi:10.1097/PR9.0000000000000785
   PubMedGoogle Scholar
• Stephens KE, Chen Z, Sivanesan E, et al. RNA-seq of spinal cord from nerve-injured rats after spinal cord stimulation. Mol Pain. 2018;14:1744806918817429. doi:10.1177/1744806918817429
   Web of Science ®Google Scholar
• Cedeño DL, Smith WJ, Kelley CA, Vallejo R. Spinal cord stimulation using differential target multiplexed programming modulates neural cell-specific transcriptomes in an animal model of neuropathic pain. Mol Pain. 2020;16:1744806920964360. doi:10.1177/1744806920964360
   Web of Science ®Google Scholar
• Smith WJ, Cedeño DL, Thomas SM, Kelley CA, Vetri F, Vallejo R. Modulation of microglial activation states by spinal cord stimulation in an animal model of neuropathic pain: comparing high rate, low rate, and differential target multiplexed programming. Mol Pain. 2021;17:1744806921999013. doi:10.1177/1744806921999013
   Web of Science ®Google Scholar
• Vallejo R, Kelley CA, Gupta A, Smith WJ, Vallejo A, Cedeño DL. Modulation of neuroglial interactions using differential target multiplexed spinal cord stimulation in an animal model of neuropathic pain. Mol Pain. 2020;16:1744806920918057. doi:10.1177/1744806920918057
   Web of Science ®Google Scholar
• Fishman MA, Calodney A, Kim P, et al. Prospective, Multicenter Feasibility Study to Evaluate Differential Target Multiplexed Spinal Cord Stimulation Programming in Subjects With Chronic Intractable Back Pain With or Without Leg Pain. Pain Pract. 2020;20(7):761–768. doi:10.1111/papr.12908
   PubMed Web of Science ®Google Scholar
• Ohemeng KK, Parham K. Vagal Nerve Stimulation: indications, Implantation, and Outcomes. Otolaryngol Clin North Am. 2020;53(1):127–143. doi:10.1016/j.otc.2019.09.008
   PubMed Web of Science ®Google Scholar
• Falvey A, Metz CN, Tracey KJ, Pavlov VA. Peripheral nerve stimulation and immunity: the expanding opportunities for providing mechanistic insight and therapeutic intervention. Int Immunol. 2022;34(2):107–118. doi:10.1093/intimm/dxab068
   PubMed Web of Science ®Google Scholar
• Tracey KJ. The inflammatory reflex. Nature. 2002;420(6917):853–859. doi:10.1038/nature01321
   PubMed Web of Science ®Google Scholar
• Koopman FA, Chavan SS, Miljko S, et al. Vagus nerve stimulation inhibits cytokine production and attenuates disease severity in rheumatoid arthritis. Proc Natl Acad Sci U S A. 2016;113(29):8284–8289. doi:10.1073/pnas.1605635113
   PubMed Web of Science ®Google Scholar
• Lerman I, Hauger R, Sorkin L, et al. Noninvasive Transcutaneous Vagus Nerve Stimulation Decreases Whole Blood Culture-Derived Cytokines and Chemokines: a Randomized, Blinded, Healthy Control Pilot Trial. Neuromodulation. 2016;19(3):283–290. doi:10.1111/ner.12398
   PubMed Web of Science ®Google Scholar
• Yuan H, Silberstein SD. Vagus Nerve Stimulation and Headache. Headache. 2017;57(Suppl 1):29–33. doi:10.1111/head.12721
   PubMed Web of Science ®Google Scholar
• Covid 19 - gammacore. Available from: https://www.gammacore.com/covid-19/. Accessed January 31, 2022.
   Google Scholar
• Genovese MC, Gaylis NB, Sikes D, et al. Safety and efficacy of neurostimulation with a miniaturised vagus nerve stimulation device in patients with multidrug-refractory rheumatoid arthritis: a two-stage multicentre, randomised pilot study. Lancet Rheumatol. 2020;2(9):e527–e538. doi:10.1016/S2665-9913(20)
   PubMedGoogle Scholar
• Sinniger V, Pellissier S, Fauvelle F, et al. A 12-month pilot study outcomes of vagus nerve stimulation in Crohn’s disease. Neurogastroenterol Motil. 2020;32(10):e13911. doi:10.1111/nmo.13911
   PubMed Web of Science ®Google Scholar
• Buchheit T, Huh Y, Maixner W, Cheng J, Ji RR. Neuroimmune modulation of pain and regenerative pain medicine. J Clin Invest. 2020;130(5):2164–2176. doi:10.1172/JCI134439
   PubMed Web of Science ®Google Scholar
• Ali M, Mohamed A, Ahmed HE, Malviya A, Atchia I. The use of ultrasound-guided platelet-rich plasma injections in the treatment of Hip osteoarthritis: a systematic review of the literature. J Ultrason. 2018;18(75):332–337. doi:10.15557/JoU.2018.0048
   PubMed Web of Science ®Google Scholar
• Anitua E, Padilla S. Biologic therapies to enhance intervertebral disc repair. Regen Med. 2018;13(1):55–72. doi:10.2217/rme-2017-0111
   PubMed Web of Science ®Google Scholar
• Di Martino A, Di Matteo B, Papio T, et al. Platelet-Rich Plasma Versus Hyaluronic Acid Injections for the Treatment of Knee Osteoarthritis: results at 5 Years of a Double-Blind, Randomized Controlled Trial. Am J Sports Med. 2019;47(2):347–354. doi:10.1177/0363546518814532
   PubMed Web of Science ®Google Scholar
• Mishra AK, Skrepnik NV, Edwards SG, et al. Efficacy of platelet-rich plasma for chronic tennis elbow: a double-blind, prospective, multicenter, randomized controlled trial of 230 patients. Am J Sports Med. 2014;42(2):463–471. doi:10.1177/0363546513494359
   PubMed Web of Science ®Google Scholar
• Chen G, Park CK, Xie RG, Ji RR. Intrathecal bone marrow stromal cells inhibit neuropathic pain via TGF-β secretion. J Clin Invest. 2015;125(8):3226–3240. doi:10.1172/JCI80883
   PubMed Web of Science ®Google Scholar
• de Witte SFH, Luk F, Sierra Parraga JM, et al. Immunomodulation By Therapeutic Mesenchymal Stromal Cells (MSC) Is Triggered Through Phagocytosis of MSC By Monocytic Cells. Stem Cells. 2018;36(4):602–615. doi:10.1002/stem.2779
   PubMed Web of Science ®Google Scholar
• Hart R, Safi A, Komzák M, Jajtner P, Puskeiler M, Hartová P. Platelet-rich plasma in patients with tibiofemoral cartilage degeneration. Arch Orthop Trauma Surg. 2013;133(9):1295–1301. doi:10.1007/s00402-013-1782-x
   PubMed Web of Science ®Google Scholar
• Pujol JP, Chadjichristos C, Legendre F, et al. Interleukin-1 and transforming growth factor-beta 1 as crucial factors in osteoarthritic cartilage metabolism. Connect Tissue Res. 2008;49(3):293–297. doi:10.1080/03008200802148355
   PubMed Web of Science ®Google Scholar
• Anwar MA, Shah M, Kim J, Choi S. Recent clinical trends in Toll‐like receptor targeting therapeutics. Med Res Rev. 2019;39(3):1053–1090. doi:10.1002/med.21553
   PubMed Web of Science ®Google Scholar
• Brown PD. Ongoing trials with matrix metalloproteinase inhibitors. Expert Opin Investig Drugs. 2000;9(9):2167–2177. doi:10.1517/13543784.9.9.2167
   PubMed Web of Science ®Google Scholar
• Tap WD, Gelderblom H, Palmerini E, et al. Pexidartinib for advanced tenosynovial giant cell tumor: results of the randomized phase 3 ENLIVEN study. Lancet. 2019;394(10197):478–487. doi:10.1016/S0140-6736(19)30764-0
   PubMed Web of Science ®Google Scholar
• Zhang W, Luo H, Zhu Z. The role of P2X4 receptors in chronic pain: a potential pharmacological target. Biomed Pharmacotherapy. 2020;129:110447. doi:10.1016/j.biopha.2020.110447
   PubMed Web of Science ®Google Scholar